43 results on '"François Puisieux"'
Search Results
2. Socio-emotional and motor engagement during musical activities in older adults with major neurocognitive impairment
- Author
-
Lise Hobeika, Matthieu Ghilain, Loris Schiaratura, Micheline Lesaffre, Dominique Huvent-Grelle, François Puisieux, and Séverine Samson
- Subjects
Medicine ,Science - Abstract
Abstract Although music therapy may engender clinical benefits in patients with neurodegenerative disease, the impacts of social and musical factors of such activities on socio-emotional and motor engagements are poorly understood. To address this issue, non-verbal behaviors of 97 patients with or without major cognitive impairment (CI) were assessed when listening to music or a metronome in front of a musician who was present physically (live) or virtually (video). Socio-emotional engagement was quantified as emotional facial expression production and gaze direction. Motor engagement was quantified as overall body motion and the production of rhythmic movements. In both groups, positive facial expressions were more frequent and rhythmic motor activities lasted longer with music than with a metronome, and during a live performance rather than a video performance. Relative to patients without CI, patients with CI moved less with music, expressed fewer emotions, and spent less time looking at the musician in the video condition and in the metronome condition. The relative reductions in motor and socio-emotional engagements in patients with CI might be markers of disease progression. However, the presence of a live partner induces older adults to engage emotionally and physically in musical activities emphasizing the relevance of using live performance as motivational levers during music therapy.
- Published
- 2021
- Full Text
- View/download PDF
3. Polypharmacy in older patients: identifying the need for support by a community pharmacist
- Author
-
Jean-Baptiste Beuscart, Ségolène Petit, Sophie Gautier, Patrick Wierre, Thibaut Balcaen, Jean-Marc Lefebvre, Nicolas Kambia, Elisabeth Bertoux, Daniel Mascaut, Christine Barthélémy, Damien Cuny, François Puisieux, and Bertrand Décaudin
- Subjects
Geriatrics ,RC952-954.6 - Abstract
Abstract Background The community pharmacist is a key player in medication reviews of older outpatients. However, it is not always clear which individuals require a medication review. The objective of the present study was to identify high-priority older patients for intervention by a community pharmacist. Methods As part of their final-year placement in a community pharmacy, pharmacy students conducted 10 interviews each with older adults (aged 65 or over) taking at least five medications daily. The student interviewer also offered to examine the patient’s home medicine cabinet. An interview guide was developed by an expert group to assess the difficulties in managing and taking medications encountered by older patients. Results The 141 students interviewed a total of 1370 patients (mean age: 81.5; mean number of medications taken daily: 9.3). Of the 1370 interviews, 743 (54.2%) were performed in the patient’s home, and thus also included an examination of the home medicine cabinet. Adverse events were reported by 566 (42.0%) patients. A total of 378 patients (27.6%) reported difficulties in preparing, administering and/or swallowing medications. The inspections of medicine cabinets identified a variety of shortcomings: poorly located cabinets (in 15.0% of inspections), medication storage problems (21.7%), expired medications (40.7%), potentially inappropriate medications (15.0%), several different generic versions of the same drug (19.9%), and redundant medications (20.4%). Conclusions In a community pharmacy setting, high-priority older patients for intervention by a community pharmacist can be identified by asking simple questions about difficulties in managing, administering, taking or storing medications.
- Published
- 2019
- Full Text
- View/download PDF
4. Persistence with osteoporosis treatment in patients from the Lille University Hospital Fracture Liaison Service
- Author
-
Anthony Delbar, Pflimlin Arnaud, Isabelle Delabrière, Camille Ternynck, Chantelot Christophe, François Puisieux, Bernard Cortet, and Julien Paccou
- Subjects
Diseases of the musculoskeletal system ,RC925-935 - Published
- 2021
- Full Text
- View/download PDF
5. Barriers and Facilitators in the Uptake of Integrated Care Pathways for Older Patients by Healthcare Professionals: A Qualitative Analysis of the French National 'Health Pathway of Seniors for Preserved Autonomy' Pilot Program
- Author
-
Lorette Lorette, Mathieu Calafiore, François Puisieux, Claire Ramez, Fanny Sarrazin, Maxime Lotin, Romain Naessens, Apolline Delesalle, Gracia Adotey, Pascal Harduin, Nathalie Leveque, Delphine Dambre, Marguerite-Marie Defebvre, Carla Di Martino, and Jean-Baptiste Beuscart
- Subjects
integrated care ,care pathway ,elderly ,frailty ,Medicine (General) ,R5-920 - Abstract
Barriers and Facilitators for Adhesion of Healthcare Professionals in Integrated Care for Older Patients: A Qualitative Assessment Based on the French National Experiment: ‘Health Pathway of Seniors for Preserved Autonomy’ (PAERPA) Introduction: Integrated care is a particularly promising approach in geriatrics – a field in which the medical, psychological and social issues are often complex. The uptake of integrated care by healthcare professionals (HCPs) is essential but varies markedly. The objective of the present study of healthcare professionals was to identify barriers to and facilitators of commitment to integrated care for seniors. Methods: We performed a two-step, qualitative study, comprising (i) six qualitative, semi-directive series of interviews with HCPs (hospital practitioners, family physicians, nurses and pharmacists) who agreed or disagreed to take part in the French national “Health Pathway of Seniors for Preserved Autonomy” (PAERPA) pilot program; and (ii) an analysis of the pooled results, in order to identify common concerns among the healthcare professionals. Results: We identified four key “barrier” and “facilitator” topics shared by HCPs who had committed to the pilot program and those who had not: (i) awareness of and/or interest in geriatric medicine and team working, (ii) the presence of a care coordinator; (iii) the provision of information about the program and about the patient, and communication between HCPs, and (iv) personal benefits for the HCPs and the patients. Key conclusions: The four key topics identified in this large qualitative study of several healthcare professions should be considered during the design and dissemination of integrated care pathways for older patients.
- Published
- 2021
- Full Text
- View/download PDF
6. Evaluation of risk factors for fall in elderly using Bayesian networks: A case study
- Author
-
Gulshan Sihag, Véronique Delcroix, Emmanuelle Grislin-Le Strugeon, Xavier Siebert, Sylvain Piechowiak, Cédric Gaxatte, and François Puisieux
- Subjects
Health data ,Knowledge model ,Fall prevention in elderly ,Bayesian network ,Classification ,Reasoning with uncertainty ,Computer applications to medicine. Medical informatics ,R858-859.7 - Abstract
Background: Falls in the elderly are the number one cause of traumatic death in this population. Prevention of falls requires to evaluate which risk factors for fall are present for a person on the basis of available health information. Our objective is to predict the presence or the absence of 12 risk factors for fall in elderly people based on partial observations.Methods: A data set of 1810 patients of the multidisciplinary falls consultation of Lille University Hospital covering fourteen years admissions were used to learn and evaluate a Bayesian network and four usual machine learning classifiers. Variable selection and data pre-processing were achieved on the basis of an ontology and interviews of the experts. The prediction of each target risk factor using the complete set of observations is first compared with the prediction based on a specific subset of variables, and second based on partial observation, from 10 to 90% of the variables.Results: For 7 out of 12 target risk factors, the f1-score of classifiers using complete set of variables is slightly better than the specific subset of variables, with a difference of less than 3%. Bayesian Networks and other classiers perform equivalently in terms of accuracy and f1-score. The best prediction were obtained for the loss of autonomy and osteoporosis with a f1-score from 15 to 20% better than the baseline classifier when using the Bayesian network. At the opposite, for 3 risk factors, no classifier allows to improve the f1-score or the accuracy of more than 1% compared to the baseline classifier.Conclusion: Our results show that the use of specific subsets of variables does not improve the prediction of risk factors, and that no classifier outperform the others. However Bayesian networks perform well and are interesting due to their explainability.
- Published
- 2021
- Full Text
- View/download PDF
7. Factors Associated with Transfer from an Acute Geriatric Unit to a Post-Acute Care Facility among Community-Dwelling Patients: Results from the DAMAGE Cohort
- Author
-
Guillaume Deschasse, Elodie Drumez, Fabien Visade, Anne Charpentier, Céline Delecluse, Gilles Loggia, Pascale Lescure, Jadwiga Attier-Żmudka, Jennifer Bloch, Cédric Gaxatte, Frédéric Bloch, François Puisieux, Jean-Baptiste Beuscart, CHU Amiens-Picardie, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Lille, Pôle de gérontologie [CHRU de Lille], Hôpital Roger Salengro [Lille]-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Mobilités : Vieillissement, Pathologie, Santé (COMETE), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Département Filière Gériatrique [CHU Caen], Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), CHirurgie, IMagerie et REgénération tissulaire de l’extrémité céphalique - Caractérisation morphologique et fonctionnelle - UR UPJV 7516 (CHIMERE), Université de Picardie Jules Verne (UPJV), Centre hospitalier de Saint-Quentin, Université de Lille, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS], METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], Mobilités : Vieillissement, Pathologie, Santé [COMETE], Université de Caen Normandie [UNICAEN], and Université de Picardie Jules Verne [UPJV]
- Subjects
care transitions ,General Medicine ,Patient Discharge ,rehabilitation ,Aged ,Humans ,Activities of Daily Living ,Subacute Care ,Independent Living ,Prospective Studies ,Geriatric Assessment ,acute geriatric unit ,health services ,risk factors ,Clinical Interventions in Aging ,Geriatrics and Gerontology ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Guillaume Deschasse,1,2 Elodie Drumez,2,3 Fabien Visade,2,4 Anne Charpentier,5 Céline Delecluse,4 Gilles Loggia,6,7 Pascale Lescure,7 Jadwiga Attier-Żmudka,8,9 Jennifer Bloch,5 Cédric Gaxatte,5 Frédéric Bloch,1 François Puisieux,5 Jean-Baptiste Beuscart2,5 1Department of Geriatrics, CHU Amiens-Picardie, Amiens, France; 2ULR 2694 - METRICS: Ãvaluation des technologies de santé et des pratiques médicales, University Lille, CHU Lille, Lille, France; 3Department of Biostatistics, CHU Lille, Lille, France; 4Geriatrics Department, Lille Catholic Hospitals, Lille, France; 5Department of Geriatrics, CHU Lille, Lille, France; 6COMETE, INSERM, Normandie Univ, UNICAEN, Caen, France; 7Department of Geriatrics, Normandie Univ, UNICAEN, CHU de Caen Normandie, Caen, France; 8Geriatric Department, General Hospital of Saint-Quentin, Saint-Quentin, France; 9CHIMERE EA 7516 Team Research, Jules Verne University, Amiens, FranceCorrespondence: Guillaume Deschasse, Department of Geriatrics, CHU Amiens-Picardie, Amiens, France, Tel +33-322-088-000, Fax + 33-322-455-748, Email deschasse.guillaume@chu-amiens.frBackground: Acute geriatric units (AGUs) require efficient discharge planning tools. Risk factors for discharge from an AGU to post-acute care (PAC) have not previously been investigated in detail.Methods: The objective is to identify risk factors for PAC transfer. The DAMAGE (prospective multicenter cohort) consecutively included more than 3500 subjects aged 75 or older and admitted to an AGU. The patients underwent a comprehensive geriatric assessment (CGA) during their stay in the AGU. Only community-dwelling patients admitted to the AGU from the emergency department were included in the analysis. We recorded the characteristics of the care pathway and identified risk factors for discharge to home or to a PAC facility.Results: 1928 patients were included. Loss of functional independence (a decrease in the Katz activities of daily living (ADL) score between 1 month prior to admission and AGU admission), living alone, social isolation, a high Katz ADL score at home, a low Katz ADL on admission, and delirium on admission were risk factors for transfer to PAC. Obesity, an elevated serum albumin level, and community-acquired infection were associated with discharge to home. Neither sex nor age was a risk factor for home discharge or transfer to PAC.Conclusion: The present results might help clinicians and discharge planning teams to identify patients at risk of transfer to PAC more reliably and promptly in AGUs.Keywords: care transitions, health services, rehabilitation, risk factors, acute geriatric unit
- Published
- 2022
- Full Text
- View/download PDF
8. Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital
- Author
-
Anne Deldicque, Pascal Odou, Jean-Baptiste Beuscart, Marc Lambert, Stéphanie Fry, Pascal de Groote, Arnaud Scherpereel, Jacques Desbordes, Bertrand Décaudin, E. Musy, Maxime Perez, Morgane Masse, and François Puisieux
- Subjects
pharmacy ,Drug ,medicine.medical_specialty ,media_common.quotation_subject ,Psychological intervention ,Pharmacy ,Pharmacists ,administration ,030226 pharmacology & pharmacy ,Hospitals, University ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Antithrombotic ,Humans ,Medicine ,Prospective Studies ,030212 general & internal medicine ,hospital ,General Pharmacology, Toxicology and Pharmaceutics ,Medical prescription ,Prospective cohort study ,Original Research ,media_common ,education ,SARS-CoV-2 ,business.industry ,COVID-19 Drug Treatment ,Clinical pharmacy ,pharmacy service ,drug-related side effects and adverse reactions ,intravenous ,medical errors ,Population study ,business - Abstract
OBJECTIVES: The objectives were to compare clinical pharmacist interventions between two care groups: COVID-19-positive and COVID-19-negative patients, and to identify drugs that require particular attention, especially those involved in COVID-19 management. METHODS: A prospective cohort study was conducted on patients with positive and negative COVID-19 statuses admitted to Lille University Hospital over 1 month. Pharmaceutical analysis instigated interventions to rectify drug-related errors. For each pharmaceutical intervention (PI), the anatomical therapeutic chemical classification of the drug and the outcome of such an intervention were specified. RESULTS: The study included 438 patients. Prescription analysis led to 188 PIs performed on 118 patients (64 COVID-19-positive patients and 54 COVID-19-negative patients). Most drug-related problems were incorrect dosage representing 36.7% (69/188) of all interventions: 27.9% (29/104) for the COVID-19-positive group and 47.6% (40/84) for the COVID-19-negative group. The most frequent PI in 34% (64/188) of cases was terminating a drug: 27.9% (29/104) for the COVID-19-positive group and 47.6% (40/84) for the COVID-19-negative group. The main drug classes involved were antithrombotic agents (20.7%, 39/188), antibacterials for systemic use (13.8%, 26/188) and drugs for gastric acid-related disorders (6.4%, 12/188). Study population was limited to a single centre over 1 month. CONCLUSION: No difference in PI was noted between the two groups. The presence of pharmacists led to a reduction in drug-related prescription problems, especially for antithrombotic and antibacterial drugs for both groups. Clinical pharmacy commitment in such a pandemic is therefore important.
- Published
- 2021
- Full Text
- View/download PDF
9. Importance of previous hospital stays on the risk of hospital re-admission in older adults: a real-life analysis of the PAERPA study population
- Author
-
Fabien Visade, Marguerite-Marie Defebvre, François Puisieux, Antoine Lamer, David Verloop, Jean-Baptiste Beuscart, Genia Babykina, Michaël Genin, and Grégoire Ficheur
- Subjects
Aging ,medicine.medical_specialty ,Multivariate analysis ,Patient Readmission ,01 natural sciences ,010104 statistics & probability ,03 medical and health sciences ,0302 clinical medicine ,Interquartile range ,Humans ,Medicine ,030212 general & internal medicine ,0101 mathematics ,Aged ,Aged, 80 and over ,Proportional hazards model ,business.industry ,General Medicine ,Emergency department ,Length of Stay ,Hospitals ,Patient Discharge ,Confidence interval ,Relative risk ,Cohort ,Emergency medicine ,Population study ,France ,Geriatrics and Gerontology ,Emergency Service, Hospital ,business - Abstract
Background consideration of the first hospital re-admission only and failure to take account of previous hospital stays, which are the two significant limitations when studying risk factors for hospital re-admission. The objective of the study was to use appropriate statistical models to analyse the impact of previous hospital stays on the risk of hospital re-admission among older patients. Methods an exhaustive analysis of hospital discharge and health insurance data for a cohort of patients participating in the PAERPA (‘Care Pathways for Elderly People at Risk of Loss of Personal Independence’) project in the Hauts de France region of France. All patients aged 75 or over were included. All data on hospital re-admissions via the emergency department were extracted. The risk of unplanned hospital re-admission was estimated by applying a semiparametric frailty model, the risk of death by applying a time-dependent semiparametric Cox regression model. Results a total of 24,500 patients (median [interquartile range] age: 81 [77–85]) were included between 1 January 2015 and 31 December 2017. In a multivariate analysis, the relative risk (95% confidence interval [CI]) of hospital re-admission rose progressively from 1.8 (1.7–1.9) after one previous hospital stay to 3.0 (2.6–3.5) after five previous hospital stays. The relative risk [95%CI] of death rose slowly from 1.1 (1.07–1.11) after one previous hospital stay to 1.3 (1.1–1.5) after five previous hospital stays. Conclusion analyses of the risk of hospital re-admission in older adults must take account of the number of previous hospital stays. The risk of death should also be analysed.
- Published
- 2020
- Full Text
- View/download PDF
10. The Nebulous Association between Cognitive Impairment and Falls in Older Adults: A Systematic Review of the Literature
- Author
-
Victoire Leroy, Valérie Martinet, Oumashankar Nunkessore, Christel Dentel, Hélène Durand, David Mockler, François Puisieux, Bertrand Fougère, and Yaohua Chen
- Subjects
Health, Toxicology and Mutagenesis ,Public Health, Environmental and Occupational Health - Abstract
Background: In older people, dementia is a well-established risk factor for falls. However, the association and the causal relationship between falls and the earlier stages of cognitive impairment remains unclear. The purpose of the study was to review the literature data on the association between falls and cognitive impairment, no dementia, including Mild Cognitive Impairment. Methods: According to PRISMA guidelines, we searched five electronic databases (EMBASE, Web of Science, Medline, CINAHL, and PsychINFO) for articles published between January 2011 and August 2022 on observational studies of older people with a cognitive assessment and/or cognitive impairment diagnosis and a recording of falls. Their quality was reviewed according to the STROBE checklist. Results: We selected 42 of the 4934 initially retrieved publications. In 24 retrospective studies, a statistically significant association between falls and cognitive status was found in only 15 of the 32 comparisons (47%). Of the 27 cross-sectional analyses in prospective studies, only eight (30%) were positive and significant. We counted four longitudinal analyses, half of which suggested a causal relationship between falls and cognitive impairment. The investigational methods varied markedly from one study to another. Conclusion: It is still not clear whether falls are associated with cognitive impairment, no dementia. Data in favor of a causal relationship are scarce. Further studies are needed to clarify their relationship.
- Published
- 2023
- Full Text
- View/download PDF
11. Sleep Medication in Older Adults:Identifying the Need for Support by a Community Pharmacist
- Author
-
Morgane Masse, Héloïse Henry, Elodie Cuvelier, Claire Pinçon, Margot Pavy, Audrey Beeuwsaert, Christine Barthélémy, Damien Cuny, Sophie Gautier, Nicolas Kambia, Jean-Marc Lefebvre, Daniel Mascaut, Fabrice Mitoumba, François Puisieux, Annie Standaert, Patrick Wierre, Jean-Baptiste Beuscart, Jean Roche, Bertrand Décaudin, Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA], Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, Université Lille Nord (France), Laboratoire Génie Civil et géo-Environnement (LGCgE) - ULR 4515, Centre Hospitalier Régional Universitaire [Lille] [CHRU Lille], Institute for Translational Research in Inflammation - U 1286 [INFINITE (Ex-Liric)], Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), and Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS)
- Subjects
Leadership and Management ,Health Policy ,[SDV]Life Sciences [q-bio] ,Health Informatics ,sleep patterns ,Article ,drug-related problems ,sedative-hypnotics ,Health Information Management ,Medicine ,community pharmacy ,sleep disorders ,benzodiazepines ,older adults ,clinical decision support system (CDSS) - Abstract
Many older adults take benzodiazepines and sedative-hypnotics for the treatment of sleep disorders. With a view to considering the possible discontinuation of hypnotics, the objectives of the present study were to describe bedtime habits and sleep patterns in older adults and to identify the sleep medications taken. An expert group developed a structured interview guide for assessing the patients’ bedtime habits, sleep patterns, and medications. During an internship in a community pharmacy, 103 sixth-year pharmacy students conducted around 10 interviews each with older adults (aged 65 or over) complaining of sleep disorders and taking at least one of the following medications: benzodiazepines, benzodiazepine derivatives (“Z-drugs”), antihistamines, and melatonin. A prospective, observational study was carried out from 4 January to 30 June 2016. The pharmacy students performed 960 interviews (with 330 men and 630 women; mean ± standard deviation age: 75.1 ± 8.8). The most commonly taken hypnotics were the Z-drugs zolpidem (n = 465, 48%) and zopiclone (n = 259, 27%). The vast majority of patients (n = 768, 80%) had only ever taken a single hypnotic medication. The median [interquartile range] prescription duration was 120 (48–180) months. About 75% (n = 696) of the patients had at least 1 poor sleep habit, and over 41% (n = 374) had 2 or more poor sleep habits. A total of 742 of the patients (77%) reported getting up at night—mainly due to nycturia (n = 481, 51%). Further, 330 of the patients (35%) stated that they were keen to discontinue their medication, of which 96 (29%) authorized the pharmacist to contact their family physician and discuss discontinuation. In France, pharmacy students and supervising community pharmacists can identify problems related to sleep disorders by asking simple questions about the patient’s sleep patterns. Together with family physicians, community pharmacists can encourage patients to discuss their hypnotic medications.
- Published
- 2022
- Full Text
- View/download PDF
12. The effect of the severity of neurocognitive disorders on emotional and motor responses to music
- Author
-
Lise Hobeika, Matthieu Ghilain, Loris Schiaratura, Micheline Lesaffre, François Puisieux, Dominique Huvent‐Grelle, and Séverine Samson
- Subjects
LIVE ,General Neuroscience ,DEMENTIA ,Emotions ,aging ,social interaction ,music intervention ,Alzheimer's disease ,General Biochemistry, Genetics and Molecular Biology ,ALZHEIMERS-DISEASE ,sensorimotor synchronization ,History and Philosophy of Science ,Medicine and Health Sciences ,Humans ,Dementia ,Music ,INTERVENTIONS - Abstract
The successful design of musical interventions for dementia patients requires knowledge of how rhythmic abilities change with disease severity. In this study, we tested the impact of the severity of the neurocognitive disorders (NCD) on the socioemotional and motor responses to music in three groups of patients with Major NCD, Mild NCD, or No NCD. Patients were asked to tap to a metronomic or musical rhythm while facing a live musician or through a video. We recorded their emotional facial reactions and their sensorimotor synchronization (SMS) abilities. Patients with No NCD or Mild NCD expressed positive socioemotional reactions to music, but patients with Major NCD did not, indicating a decrease in the positive emotional impact of music at this stage of the disease. SMS to a metronome was less regular and less precise in patients with a Major NCD than in patients with No NCD or Mild NCD, which was not the case when tapping with music, particularly in the presence of a live musician, suggesting the relevance of live performance for patients with Major NCD. These findings suggest that the socioemotional and motor reactions to music are negatively affected by the progression of the NCD.
- Published
- 2022
13. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People
- Author
-
Dominique Huvent-Grelle, Julie Demaret, Alain Duhamel, Annie Sobaszek, Juliette Podvin, Fanny Vuotto, Laurence Bocket, Sophie Miczek, François Puisieux, Enagnon Kazali Alidjinou, Anne Goffard, Michael Hisbergues, Guillaume Lefèvre, Julien Labreuche, Arnaud Dendooven, Dominique Deplanque, Jacques Trauet, Bénédicte Corroyer-Simovic, Karine Faure, Myriam Labalette, Daniel Dreuil, Université de Lille, Inserm, CHU Lille, Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017, Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286, Lille Neurosciences & Cognition (LilNCog) - U 1172, Institute for Translational Research in Inflammation - U 1286 [INFINITE (Ex-Liric)], Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Hôpital Gériatrique Les Bateliers [Lille] (USLD - Nord), Pathogenèse virale du diabète de type 1 - ULR 3610 (Laboratoire de Virologie), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Impact de l'environnement chimique sur la santé humaine - ULR 4483 (IMPECS), Centre d'Investigation Clinique - Innovation Technologique de Lille - CIC 1403 - CIC 9301 (CIC Lille), Santé Publique : épidémiologie et qualité des soins (EA 2694), Faculté de Médecine Henri Warembourg - Université de Lille-Centre d'Etudes et de Recherche en Informatique Médicale [Lille] (CERIM), and Université de Lille, LillOA
- Subjects
Adult ,Male ,T cells response ,Immunosenescence ,T-Lymphocytes ,[SDV]Life Sciences [q-bio] ,T cell ,Immunology ,Nutritional Status ,Antibodies, Viral ,Immunogenicity, Vaccine ,Immune system ,vaccine ,medicine ,Humans ,Immunology and Allergy ,BNT162 Vaccine ,Original Research ,Aged, 80 and over ,Frailty ,biology ,SARS-CoV-2 ,business.industry ,ELISPOT ,mRNA vaccination ,Antibody titer ,COVID-19 ,RC581-607 ,Middle Aged ,Antibodies, Neutralizing ,[SDV] Life Sciences [q-bio] ,medicine.anatomical_structure ,SARS - CoV - 2 ,older people and ageing ,"SARS - CoV - 2" ,Humoral immunity ,biology.protein ,SARS – CoV – 2 ,Female ,Immunologic diseases. Allergy ,Antibody ,business ,CD8 - Abstract
Long-term care facility (LTCF) older residents display physiological alterations of cellular and humoral immunity that affect vaccine responses. Preliminary reports suggested a low early postvaccination antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to focus on the specific T-cell response. We quantified S1-specific IgG, neutralizing antibody titers, total specific IFNγ-secreting T cells by ELISpot, and functionality of CD4+- and CD8+-specific T cells by flow cytometry, after two doses of the BNT162b2 vaccine in younger and older people, with and without previous COVID-19 infection (hereafter referred to as COVID-19-recovered and COVID-19-naive subjects, respectively). Frailty, nutritional, and immunosenescence parameters were collected at baseline in COVID-19-naive older people. We analyzed the immune response in 129 young adults (median age 44.0 years) and 105 older residents living in a LCTF (median age 86.5 years), 3 months after the first injection. Humoral and cellular memory responses were dramatically impaired in the COVID-19-naive older (n = 54) compared with the COVID-19-naive younger adults (n = 121). Notably, older participants’ neutralizing antibodies were 10 times lower than the younger’s antibody titers (p + and IFNγ+IL-2+TNFα+ cells among specific CD4+ T cells, and the frequency of specific CD8+ T cells were lower in COVID-19-naive older participants than in COVID-19-naive young adults (p p = 0.0018, respectively). However, COVID-19-recovered older participants (n = 51) had greater antibody and T-cell responses, including IFNγ+ and IFNγ+IL-2+TNFα+-specific CD4+ T cells (p +-specific CD8+ T cells (p + and CD8+ T cells, in addition to impaired antibody response, and that specific studies are warranted to assess the efficiency of SARS-CoV-2 mRNA-based vaccines, as in other immunocompromised subjects. Our study also shows that, despite their physiological alterations of immunity, vaccination is highly efficient in boosting the prior natural memory response in COVID-19-recovered older people.
- Published
- 2021
- Full Text
- View/download PDF
14. Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection
- Author
-
K. Faure, Annie Sobaszek, F. Vuotto, Enagnon Kazali Alidjinou, B. Corroyer-Simovic, J. Podvin, Dominique Huvent-Grelle, Alain Duhamel, Anne Goffard, Julien Labreuche, Dominique Deplanque, Arnaud Dendooven, Miczek S, François Puisieux, Guillaume Lefèvre, Julie Demaret, Myriam Labalette, Laurence Bocket, Jacques Trauet, and Daniel Dreuil
- Subjects
biology ,business.industry ,T cell ,Antibody titer ,Titer ,medicine.anatomical_structure ,Immune system ,Immunology ,biology.protein ,Medicine ,Young adult ,Antibody ,business ,Neutralizing antibody ,CD8 - Abstract
We quantified S1-specific IgG, neutralizing antibody titers, specific IFNγ secreting T cells and functionality of specific CD4+ and CD8+ T cells in 130 young adults (median age 44.0 years) and 106 older residents living in a long-term care facility (86.5 years) after 2 doses of BNT162b2. Three months after the first injection, humoral and cellular memory responses were dramatically impaired in the 54 COVID-19-naive older compared to the 121 COVID-19-naive younger adults. Notably, older participants’ neutralizing antibodies, detected in 76.5% (versus 100% in young adults,P< 0.0001), were ten times lower than the younger’s antibody titers (P< 0.0001). Antibody and T cell responses were greater among the 52 COVID-19-recovered than among the 54 COVID-19-naive older adults (P< 0.0001). Our study shows that 2 doses of BNT162b2 does not guarantee long-term protection against SARS-CoV-2 in the older. An additional dose should be considered to boost their specific memory response.
- Published
- 2021
- Full Text
- View/download PDF
15. A knowledge based system for the management of a time stamped uncertain observation set with application on preserving mobility
- Author
-
Emmanuelle Grislin-Le Strugeon, Véronique Delcroix, François Puisieux, Laboratoire d'Automatique, de Mécanique et d'Informatique industrielles et Humaines - UMR 8201 (LAMIH), and Centre National de la Recherche Scientifique (CNRS)-Université Polytechnique Hauts-de-France (UPHF)-INSA Institut National des Sciences Appliquées Hauts-de-France (INSA Hauts-De-France)
- Subjects
Computer science ,Reliability (computer networking) ,media_common.quotation_subject ,Context (language use) ,02 engineering and technology ,computer.software_genre ,Theoretical Computer Science ,Knowledge-based systems ,Artificial Intelligence ,020204 information systems ,0202 electrical engineering, electronic engineering, information engineering ,Knowledge based system ,Quality (business) ,[INFO]Computer Science [cs] ,Reasoning with uncertainty ,Set (psychology) ,Information quality ,Probabilistic graphical model ,media_common ,Applied Mathematics ,Probabilistic logic ,Information aging ,Uncertain information ,020201 artificial intelligence & image processing ,Data mining ,State (computer science) ,computer ,Software - Abstract
International audience; The aim of this study is to maintain up-to-date information about the current state of elderly people that are medically followed for risks of fall. Our proposal consists of an individual information database management system that can provide information on-demand on various variables. Such a system has to deal with several sources of uncertainty: lack of information, evolving information and reliability of the information sources. We consider that the features of the person may evolve with time causing uncertainty due to obsolete information. Our context includes new information received bit by bit, with no possibility to collect all required information at once. This paper establishes a first proposal to manage a set of uncertain observations, in order to reduce erroneous and obsolete information while keeping the benefit of previously collected information. We propose an architecture of the system based on a probabilistic knowledge model about the characteristics of interest, a set of decay functions that help to evaluate the confidence degree in previous observations, and a reasoning module to manage new observations, maintain the compatibility and the quality of the observation set. We detail the algorithms of the reasoning module, and the algorithm to update the confidence degree of the observations.
- Published
- 2021
- Full Text
- View/download PDF
16. Does a Live Performance Impact Synchronization to Musical Rhythm in Cognitively Impaired Elderly?
- Author
-
Séverine Samson, Dominique Huvent-Grelle, Joren Six, Loris Schiaratura, Micheline Lesaffre, Ashmita Singh, Matthieu Ghilain, François Puisieux, Lise Hobeika, Psychologie : Interactions, Temps, Emotions, Cognition (PSITEC) - ULR 4072 (PSITEC), Université de Lille, Sciences et Technologies de la Musique et du Son (STMS), Institut de Recherche et Coordination Acoustique/Musique (IRCAM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Universiteit Gent = Ghent University (UGENT), Department of Medicine [Toronto, Canada], Mt. Sinai Hospital [Toronto, Canada]-University of Toronto [Canada]-Lunenfeld-Tanenbaum Research Institute [Toronto, Canada], Hôpital des bateliers, CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), IPEM, Department of Arts, Music and Theater Sciences, Ghent University, Belgium, and Mt. Sinai Hospital [Toronto, Canada]-Lunenfeld-Tanenbaum Research Institute [Toronto, Canada]-University of Toronto [Canada]
- Subjects
Male ,Aging ,InformationSystems_INFORMATIONINTERFACESANDPRESENTATION(e.g.,HCI) ,Psychological intervention ,Video Recording ,Audiology ,Social Environment ,Social interaction ,Motor activity ,law.invention ,0302 clinical medicine ,law ,Aged, 80 and over ,General Neuroscience ,05 social sciences ,Cognition ,General Medicine ,Alzheimer's disease ,humanities ,Psychiatry and Mental health ,Clinical Psychology ,Cognitive impairment ,[SCCO.PSYC]Cognitive science/Psychology ,Female ,Psychology ,medicine.medical_specialty ,Music therapy ,Metronome ,050105 experimental psychology ,03 medical and health sciences ,Alzheimer Disease ,medicine ,Dementia ,Humans ,0501 psychology and cognitive sciences ,Cognitive Dysfunction ,Cognitive skill ,Music Therapy ,Aged ,[SCCO.NEUR]Cognitive science/Neuroscience ,Dementia, Vascular ,Social environment ,medicine.disease ,Social relation ,Acoustic Stimulation ,Geriatrics and Gerontology ,030217 neurology & neurosurgery ,Music ,Psychomotor Performance - Abstract
International audience; Background Music-based interventions appear to be efficient non-pharmacological approaches to improve emotional, social, and cognitive functioning of patients with neurodegenerative diseases such as Alzheimer's Disease (AD). Objectives Because the benefits seem to increase with patients motor involvement, we studied the ability to move in synchrony with musical rhythms and more specifically the impact of live performance compared to video recording of a musician on sensorimotor abilities in patients with cognitive impairments (AD, vascular and mixed dementia) and in patients with no evidence of cognitive impairments. Methods Sensorimotor synchronization (SMS) to a metronomic or a musical stimulus was assessed in patients when they were viewing a live musician or his pre-recorded video. Results Participants were better at synchronizing to a metronome than to music but this effect was modulated by the social context. While SMS to a metronome was better when facing a video than a live performance, there was no impact of the social context on SMS to music. Lastly, we found no group differences on SMS. Conclusion The decrease in synchronization ability to metronome in the live performance may be due to the social pressure associated with the presence of the musician. Such a pressure might be removed in pleasant and ecological social activities, like moving with music, explaining the lack of the social context effect on SMS to music. Remarkably, the group with cognitive impairments performed no worse than the group without cognitive impairments, which suggests relatively spared SMS abilities in these patients. By showing that it is possible to encourage a patient to synchronize with others, even in front of a video, the results of our study indicate that SMS can be used as a relevant predictor in clinical trials and open up promising therapeutic options for patients living in remote areas.
- Published
- 2020
- Full Text
- View/download PDF
17. Persistence with osteoporosis treatment in patients from the Lille University Hospital Fracture Liaison Service
- Author
-
Isabelle Delabriere, Anthony Delbar, Camille Ternynck, Julien Paccou, François Puisieux, Arnaud Pflimlin, Bernard Cortet, and Christophe Chantelot
- Subjects
0301 basic medicine ,Persistence (psychology) ,Adult ,Male ,medicine.medical_specialty ,Histology ,Physiology ,Endocrinology, Diabetes and Metabolism ,Osteoporosis ,030209 endocrinology & metabolism ,Diseases of the musculoskeletal system ,Persistence (computer science) ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Osteoporosis treatment ,Teriparatide ,medicine ,Humans ,Orthopedics and Sports Medicine ,In patient ,Aged ,Service (business) ,Bone Density Conservation Agents ,business.industry ,Odds ratio ,Middle Aged ,medicine.disease ,University hospital ,Hospitals ,Spine ,Discontinuation ,030104 developmental biology ,Zoledronic acid ,Denosumab ,RC925-935 ,Emergency medicine ,Population study ,Female ,business ,Osteoporotic Fractures ,medicine.drug - Abstract
Purpose/introduction A Fracture Liaison Service (FLS) was set up at Lille University Hospital in 2016. The purpose of this study was to assess persistence with osteoporosis treatment in patients from the FLS over a period of 1 year, and to determine predictors of discontinuation. Methods The study population comprised adults of both genders, aged 50 or over, admitted to Lille University Hospital between January 2016 and January 2019 for a low-trauma fracture and managed in our FLS. Outcomes included (1) persistence rate at 1 year after treatment initiation, (2) persistence rate at 2 years after treatment initiation, (3) persistence rate at 1 and 2 years after treatment initiation according to type of treatment, (4) predictors of non-persistence, and (5) reasons for discontinuing treatment over 1 year after initiation. Persistence was determined using the Kaplan–Meier method. Results In all, 1224 patients (≥50 years old) with a recent history of low-trauma fracture (≤12 months) were identified. Of these, 380 patients – 79.2% female; mean (SD) age 76 (11) years – were seen at the FLS. In those 380 patients, 410 fractures were found and 360 of them (87.8%) were major fractures, breaking down as follows: vertebra (44%), hip (19%), proximal humerus (10%), and pelvis (8%). Osteoporosis treatment was prescribed for 367 (96.6%) patients and 275 of them began the prescribed treatment. The following anti-osteoporosis drugs were prescribed: zoledronic acid (n=150, 54.5%), teriparatide (n=63, 22.9%), and denosumab (n=39, 14.2%). Oral bisphosphonates were prescribed for a few patients (n=23, 8.4%). Persistence with osteoporosis medication (any class) was estimated at 84.1% (95% CI: 79.1% to 88.1%) at 12-month follow-up, and dropped to 70.3% (95% CI: 63.7% to 75.9%) at 24 months. When drug-specific analyses were performed using the Kaplan–Meier method, persistence rates at 12 and 24 months were found to be higher with denosumab than with any other treatment. Independent predictors of non-persistence at 12 months were ‘follow-up performed by a general practitioner (GP)’ – Odds Ratio (OR) for GP vs. FLS = 3.68; 95% CI, 1.52 to 8.90, p=0.004 – and ‘treatment with zoledronic acid’ – OR for zoledronic acid vs. denosumab = 3.39; 95% CI, 1.21 to 9.50, p=0.019; OR for zoledronic acid vs. teriparatide = 8.86; 95% CI, 1.15 to 68.10, p=0.035. Conclusions This study provides evidence of the success of our FLS in terms of long-term persistence with osteoporosis treatments. However, osteoporosis treatment initiation still needs to be improved.
- Published
- 2020
18. Résultats préliminaires de l’évaluation de l’immunogénicité du vaccin anti-SARS-CoV-2 BNT162b2 chez le sujet âgé versus l’immunité naturelle post-COVID-19
- Author
-
E. Alidjinou, G. Lefevre, François Puisieux, B. Corroyer-Simovic, Julie Demaret, M. Labalette, and Anne Goffard
- Subjects
Covid-39 ,Infectious Diseases - Abstract
Introduction La pandemie a COVID-19 est responsable de pres de 3 millions de deces. En l’absence de traitement curatif a ce jour, la prevention est la seule strategie efficace pour la controler. La vaccination est un des piliers de cette prevention. Elle a commence par les sujets les plus fragiles, les residents d’etablissement d’hebergement pour personnes âgees dependantes (EHPAD). Ils ont beneficie des premiers vaccins disponibles a ARN messager depuis le 28 decembre 2020. Ils presentent une immunosenescence physiologique a l’origine habituellement d’une immunite innee moins efficiente et ou d’une immunite adaptative moins durable. Les donnees concernant cette population âgee particuliere sont absentes que ce soit sur la reponse immunitaire naturelle versus l’immunite vaccinale et les facteurs (âge, comorbidites, statut nutritionnel) pouvant modifier les reponses du systeme immunitaire. L’objectif de ce travail est de comparer la qualite de la reponse vaccinale anti-SARS-CoV-2 versus l’immunite naturelle. Materiels et methodes Etude observationnelle prospective monocentrique d’une cohorte de residents d’EHPAD et d’unites de soins de longue duree de plus de 65 ans d’un centre hospitalo-universitaire francais. Les residents beneficient de la vaccination par COMINARTY (BNT162b2), 2 doses a 21 jours d’intervalle. Les objectifs sont de comparer la reponse immunitaire specifique 3 mois apres COVID-19 et 3 mois apres la vaccination. Elle evalue le nombre de lymphocytes T totaux specifiques anti-S et d’anticorps neutralisants (Virus neutralization test) 3 mois apres une infection COVID-19 prouvee avant toute vaccination et 3 mois apres la vaccination chez les sujets « naifs ». La qualite de reponse immunitaire postvaccinale est evaluee en comparant l’amplitude, le nombre de lymphocytes T, d’anticorps totaux anti-S en fonction de la presence d’anticorps prevaccinaux (infection anterieure). La qualite de la reponse immunitaire est comparee en fonction de l’etat nutritionnel des sujets âges et des indicateurs d’immunosenescence sur l’immunite adaptative (nombre de lymphocytes T, taux d’anticorps totaux anti-S et d’anticorps neutralisants en fonction des taux basals de cytokines proinflammatoires, du pourcentage et du nombre absolu de lymphocytes CD4+ naifs, lymphocytes CD8+ de differenciation terminale). Resultats Seules les donnees pour les reponses a 3 mois seront disponibles pour cette communication. Description de la population : EHPAD de 104 lits et USDL de 96 lits avec 162 residents presents avec une moyenne d’âge de 83 ans et des comorbidites lourdes avec un GIR moyen pondere de 761 en EHPAD et de 865 en USLD. Quatre-vingt-sept residents ont presente une infection a COVID-19 documentee entre mars et decembre 2020. Quatre-vingt-quinze pour cent des residents ont beneficie d’une vaccination anti-SARS-CoV-2 et 90 % ont accepte la participation a l’etude. Les premieres donnees a 3 mois en Elispot apres immunisation naturelle anti-S : – sujets > 65 ans : mediane 33 spots (n = 34) ; – sujets > 75 ans : mediane 22 spots (n = 13). Conclusion A suivre.
- Published
- 2021
- Full Text
- View/download PDF
19. Résultats préliminaires de l’évaluation de la réponse immunitaire du vaccin anti-SARS-CoV2 BNT162b2 chez le sujet âgé versus l’immunité naturelle post-COVID
- Author
-
F. Vuotto, E. Alidjinou, Annie Sobaszek, Julie Demaret, G. Lefevre, François Puisieux, M. Labalette, B. Corroyer-Simovic, and Anne Goffard
- Subjects
Infectious Diseases ,Col8-05 - Abstract
Introduction La pandémie à COVID-19 est responsable de près de 3 millions de décès. En l’absence de traitement curatif à ce jour, la prévention est la seule stratégie efficace pour la contrôler. La vaccination est un des piliers de cette prévention. Elle a commencé par les sujets les plus fragiles, les résidents d’établissement d’hébergement pour personnes âgées dépendantes (EHPAD). Ils ont bénéficié des premiers vaccins disponibles à ARN messager depuis le 28 décembre 2020. Ils présentent une immunosénescence physiologique à l’origine habituellement d’une immunité innée moins efficiente et ou d’une immunité adaptative moins durable. Les données concernant cette population âgée particulière sont absentes sur la réponse immunitaire vaccinale et les facteurs (âge, comorbidités, statut nutritionnel) pouvant modifier les réponses du système immunitaire. L’objectif de ce travail est de comparer la qualité de la réponse vaccinale anti-SARS-CoV-2 par rapport à des sujets immunocompétents de 18 à 65 ans. Matériels et méthodes Étude observationnelle prospective monocentrique d’une cohorte de résidents d’EHPAD et d’unités de soins de longue durée de plus de 65 ans d’un centre hospitalo-universitaire français par rapport à des professionnels de santé et du médicosocial de 18 à 65 ans. Les 2 groupes bénéficient de la vaccination par COMINARTY(BNT162b2), 2 doses à 21 jours d’intervalle. Les objectifs sont : – évaluer l’amplitude de la réponse lymphocytaire T totale anti-S à 3 mois : nombre de cellules sécrétrices d’interféron gamma ; – évaluer l’amplitude de la réponse lymphocytaire T CD4+ et T CD8+ spécifique anti-S à 3 et 9 mois (nombre de lymphocytes T spécifiques anti-S détectés à 3 et 9 mois, après enrichissement en T CD4+ et en T CD8+) ; – évaluer l’amplitude de la réponse humorale spécifique anti-S à 3 et 9 mois (taux d’anticorps totaux anti-S et d’anticorps neutralisants). Seules les données pour les réponses à 3 mois seront disponibles pour cette communication. Résultats Description de la population: EHPAD de 104 lits et USDL de 96 lits avec 162 résidents présents avec une moyenne d’âge de 83 ans et des comorbidités lourdes avec un GIR moyen pondéré de 761 en EHPAD et de 865 en USLD. Quatre-vingt-sept résidents ont présenté une infection à COVID-19 documentée entre mars et décembre 2020. Quatre-vingt-quinze pour cent des résidents ont bénéficié d’une vaccination anti-SARS-CoV-2 et 90 % ont accepté la participation à l’étude. Pour le groupe contrôle 125 professionnels du CHU ont été inclus à l’étude en collaboration avec l’équipe de la médecine du travail et le centre de vaccination. Les premières données à 3 mois en Elispot après immunisation naturelle anti-S : – sujets 65 ans : médiane 33 spots (n = 34) ; – sujets > 75 ans : médiane 22 spots (n = 13). Conclusion À suivre.
- Published
- 2021
- Full Text
- View/download PDF
20. Association between anticholinergic burden and hospital readmission in older patients: a prospective analysis
- Author
-
Rachid Mahmoudi, Sophie Castier, François Puisieux, Jean-Baptiste Beuscart, Fabien Visade, and Cristian Preda
- Subjects
Aged, 80 and over ,Male ,Hospital readmission ,medicine.medical_specialty ,business.industry ,medicine.drug_class ,General Medicine ,030204 cardiovascular system & hematology ,Patient Readmission ,Risk Assessment ,03 medical and health sciences ,Prospective analysis ,0302 clinical medicine ,Older patients ,Emergency medicine ,Anticholinergic ,Medicine ,Humans ,Anticholinergic Syndrome ,Female ,030212 general & internal medicine ,Prospective Studies ,business ,Adverse effect ,Aged - Abstract
Despite known adverse effects of anticholinergic (AC) medication, little work has been devoted to the impact of high anticholinergic burden on the rate of hospital readmission. The purpose of this study was to analyze prospectively the link between high AC burden and the rate of all-cause thirty-day hospital readmission in older people. This was a prospective non-interventional study conducted from January to August 2019 in one acute-care geriatric ward. All hospital stays of patients aged at least 75 years who were discharged to their home were included in the analysis. AC burden was determined from discharge prescriptions using the Anticholinergic Drug Scale (ADS) and the Anticholinergic Risk Scale (ARS), and defined as high if ≥3. The analysis concerned 350 hospital stays. Median patient age was 88 years (interquartile interval 84–91). In a multivariate analysis, the risk of hospital readmission within 30 days was not increased for patients with high AC burden (ADS≥3): odds ratio 1.16 [95% confidence interval 0.56–2.37], compared to a patient whose anticholinergic burden was not high. Unlike retrospective studies on this issue, the findings of our prospective analysis do not support a higher risk of hospital admission within 30 days for older people with high AC burden as assessed from their discharge prescriptions.
- Published
- 2020
- Full Text
- View/download PDF
21. Hip fractures and characteristics of living area: a fine-scale spatial analysis in France
- Author
-
Michaël Genin, R. Héquette-Ruz, Jean-Baptiste Beuscart, E. Guillaume, François Puisieux, Emmanuel Chazard, Grégoire Ficheur, Julien Paccou, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Registre des Tumeurs Digestives [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER, Marrow Adiposity & Bone Lab - Adiposité Médullaire et Os - ULR 4490 (MABLab (ex-pmoi)), Université du Littoral Côte d'Opale (ULCO)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-UNICANCER, Université de Lille, CHU Lille, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, 45509|||Registre des Tumeurs Digestives [CHU Caen], and Marrow Adiposity & Bone Lab - Adiposité Médullaire et Os - ULR 4490 [MABLab (ex-pmoi)]
- Subjects
0301 basic medicine ,Endocrinology, Diabetes and Metabolism ,[SDV]Life Sciences [q-bio] ,030209 endocrinology & metabolism ,Hip fracture ,03 medical and health sciences ,0302 clinical medicine ,Elderly ,Residence Characteristics ,medicine ,Humans ,Ecological factors ,Spatial regression ,Aged ,Aged, 80 and over ,Spatial Analysis ,business.industry ,Spatial structure ,Hip Fractures ,Incidence (epidemiology) ,Incidence ,Hospital discharge database ,Middle Aged ,medicine.disease ,Social deprivation ,Standardized mortality ratio ,Scale (social sciences) ,National database ,030101 anatomy & morphology ,France ,business ,Demography - Abstract
Résumé : Nous avons étudié l'association entre l'incidence des fractures de la hanche et les caractéristiques du lieu de vie en France. La répartition spatiale de l'incidence des fractures de la hanche était hétérogène et il existait une relation significative entre la privation sociale, l'urbanisation, l'accès à la santé et le risque de fracture de la hanche. Objectif : Plusieurs études ont montré de grandes disparités dans la répartition spatiale des fractures de hanche (FH). L'objectif de l'étude était d'analyser l'association entre l'incidence des FH et les caractéristiques du lieu de vie. Méthodes : Tous les patients âgés de 50 ans ou plus, résidant en France, qui ont été hospitalisés pour une HF entre 2012 et 2014 ont été inclus, en utilisant la base de données nationale française des sorties d'hôpital. Les ratios d'incidence standardisés (SIR) ont été calculés pour chaque unité spatiale et ajustés sur l'âge et le sexe. Une régression écologique a été réalisée pour analyser l'association entre l'incidence standardisée de l'HF et les variables écologiques. Nous avons ajusté le modèle pour la structure spatiale du quartier. Nous avons utilisé trois variables pour caractériser les zones de vie : un indice de privation (French-EDI) ; l'accès aux soins (indice standardisé français) ; l'utilisation du sol (pourcentage de surfaces artificialisées). Résultats : 236 328 HF ont été enregistrées dans la base de données nationale des hôpitaux français, conduisant à une incidence annuelle d'HF de 333/100 000. L'analyse spatiale a révélé des variations géographiques de l'incidence de l'HF avec un SIR variant de 0,67 [0,52 ; 0,85] à 1,45 [1,23 ; 1,70]. Il y avait une association significative entre les taux d'incidence de l'HF et : (1) l'indice French-EDI (tendance p=0,0023) ; (2) l'accessibilité des médecins généralistes et des infirmières (tendance p=0,0232 et p=0,0129, respectivement) ; (3) le pourcentage de surfaces artificialisées (p
- Published
- 2019
- Full Text
- View/download PDF
22. Proposition of a structured list of information items to be transmitted to primary caregivers after in-hospital medication optimization: a qualitative study
- Author
-
François Puisieux, Antoine Lefebvre, Fabien Visade, Jean-Baptiste Beuscart, Emmanuel Floret, Céline Delecluse, and Bertrand Décaudin
- Subjects
business.industry ,Hospital unit ,Liver and kidney ,Primary care physician ,General Medicine ,medicine.disease ,Pharmacists ,Focus group ,Hospitals ,Patient Discharge ,03 medical and health sciences ,0302 clinical medicine ,Older patients ,Caregivers ,General Practitioners ,030220 oncology & carcinogenesis ,Medicine ,Humans ,030212 general & internal medicine ,Medical emergency ,Drug reaction ,business ,Adverse effect ,Qualitative research ,Aged - Abstract
Background and objective: Defective transmission of drug information during the transition from hospital to home care are causes of adverse drug reactions in older patients. We aimed to reach a consensus concerning information about changes in treatment to be transmitted to primary caregivers when an older patient is discharged from hospital. Methods: A qualitative focus group study was conducted with general practitioners, geriatricians, community pharmacists, and hospital pharmacists providing care for older patients. Four steps were used to reach a focus group consensus: 1) presentation of the purpose of the focus group; 2) generation and enumeration of ideas; 3) sharing opinions about these ideas; 4) voting to create a list of ranked items. The process involved three focus groups. Results: A consensus was reached on ten items: indication for continued, discontinued, newly introduced or changed treatments and their duration; reasons for discontinuing drugs or introducing new drugs; information about re-evaluating treatments; reasons for hospital stay, significant elements and diagnosis at discharge; administrative information concerning the patient; the name of the primary care physician, and the discharging hospital unit and the physician(s) in charge; known allergies, information about liver and kidney failure; main adverse effects to monitor; date of latest blood tests; hospital admission/discharge dates. Conclusion: The consensus on the list of information items concerning changes in the treatment should be used by hospital physicians and pharmacists to ensure safe patient discharge.
- Published
- 2019
- Full Text
- View/download PDF
23. Predictors of cognitive anosognosia in older adults with suspected dementia
- Author
-
Pascal Antoine, François Puisieux, Jean Roche, Dominique Huvent-Grelle, and Emilie Avondino
- Subjects
Activities of daily living ,Anosognosia ,medicine ,Neuropsychology ,Anxiety ,Dementia ,Cognition ,Apathy ,Cognitive skill ,medicine.symptom ,medicine.disease ,Psychology ,Clinical psychology - Abstract
Objective: Anosognosia heterogeneously affects cognitive functioning and indeed, at the very onset of dementia symptoms. This raises the question of accountable predictors of each cognitive impairment. The objective of this study was to identify the cognitive and non-cognitive predictors of so-called cognitive anosognosia. Method: A paradigm based on the discrepancies between performance predictions and actual performance in the light of the Dementia Rating Scale (DRS) helped distinguish cognitive anosognosia in relation to four major functions: Attention Initiation-perseveration, Conceptualisation and Memory. Patients achieved a complete set of neuropsychological tests and assessments of the level of anxiety, apathy and functional independence. Results: Significant correlations existed between all cognitive anosognosia scores (AS) and neuropsychological performance scores of the participants. Similarly, significant correlations were found between the Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) scores and the Initiation and Conceptualisation AS and between anxiety score and Conceptualisation and Memory AS. However, the regression models were exclusively cognitive for Attention Initiation-perseveration and Memory AS. Only the Conceptualisation AS was predicted by a non-strictly cognitive regression model including the ADL score. Conclusions: If the different specific cognitive anosognosias are predicted by separate sets of variables, our results emphasise that dysexecutive impairment plays a major role regardless of the deficiencies considered.
- Published
- 2018
- Full Text
- View/download PDF
24. Case Report: Ocular Microsporidiosis: Case in a Patient Returning from India and Review of the Literature
- Author
-
Anne-Sophie Deleplancque, Pierre Labalette, Olivier Gaillot, Séverine Loridant, Boualem Sendid, Aldert Bart, François Puisieux, Marjorie Cornu, Tom van Gool, E. Dutoit, Emilie Fréalle, and Jordan Leroy
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Conjunctiva ,Antifungal Agents ,030106 microbiology ,Keratoconjunctivitis ,India ,Microsporidiosis ,Cornea ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Vittaforma ,Virology ,medicine ,Humans ,Travel ,biology ,business.industry ,Articles ,Eye infection ,Middle Aged ,biology.organism_classification ,medicine.disease ,Dermatology ,Infectious Diseases ,medicine.anatomical_structure ,Debridement ,Microsporidia ,030221 ophthalmology & optometry ,Etiology ,Parasitology ,sense organs ,France ,business ,Eye Infections, Fungal ,Fluoroquinolones - Abstract
Microsporidia are protists close to the kingdom of fungi that may cause eye infections. Most cases are reported in Asia and affect both immunocompromised and immunocompetent patients. Here, we report a rare case of microsporidial keratoconjunctivitis in an immunocompetent French patient 3 weeks after returning from India. In our patient, Weber trichrome staining of conjunctival scrapings revealed rounded elements approximately 1-3 μm in size. Conventional polymerase chain reaction analysis by ribosomal RNA subunit sequencing showed 100% identity with Vittaforma corneae. Treatment by corneal debridement combined with fluoroquinolone eye drops allowed complete resolution of the lesions. Although rare, ocular microsporidiosis should be investigated in a patient who is native to Asia or has returned from an endemic area and presents with keratoconjunctivitis of undetermined etiology.
- Published
- 2018
25. Operational definition of Active and Healthy Ageing (AHA)
- Author
-
Henriette A. Smit, Neil Wilson, Jean-Marie Robine, J. Y. Pelissier, M. Van Beurden, A. Bedbrook, T. Standberg, Vittorio Romano, Bertrand Fougère, J. Garcia-Aymerich, C. Jeandel, Anne Hendry, B. Samolinski, Mike Bewick, Holger Schulz, P. Bertone, Yoav Ben-Shlomo, J. Coletta, D. Poethig, J. P. Michel, Valentina A. Andreeva, M. O'Neill, M. Nogues, K. Andersen Ranberg, Elena Villalba-Mora, Daniel Laune, Itziar Vergara, Maddalena Illario, F. Roubille, G. J. Buijs, J. Venne, Sylvie Arnavielhe, L. Rodriguez Manas, Carol Brayne, David Somekh, T. Camuzat, Jacques Bringer, A. Nizinkska, Marcel Goldberg, Carel Thijs, Alessandro Blasimme, Raphaëlle Varraso, Dieter Maier, Marie Zins, D. Heve, François Puisieux, Theodore D. Cosco, D. Harman, João O. Malva, Thomas Keil, Rachel Cooper, J. Mercier, M. Criton, Alfredo Cesario, Philippe-Jean Bousquet, Jean Bousquet, Davide Caimmi, John Farrell, Emmanuelle Kesse-Guyot, Dirkje S. Postma, Karen Ritchie, Joël Ankri, P. Viriot-Durandal, Pascal Demoly, G. Moda, V. Traver-Salcedo, Susanne Krauss-Etschmann, Daniela Porta, D. Kula, Jordi Alonso, Federico Alonso, Ana Todo-Bom, Frédéric Cuisinier, R. Pengelly, Guido Iaccarino, G. Mercier, C. Robalo-Cordeiro, Eveline Wouters, P. Senesse, P. Matignon, J. Touchon, Sergio Bonini, B. Combe, J. Suanzes, Marek L. Kowalski, A. Zaidi, Isabelle Momas, R. Bourret, Hasan Arshad, A. Avignon, Sylvain Lehmann, Ana Maria Carriazo, Diana Kuh, Claudine Berr, Mai Stafford, A. Scott, Marcus Richards, S. Fernandez-Nocelo, Rebecca Hardy, Z. Gutter, M. E. Joel, Erik Melén, C. Tischer, Sandra N. Slagter, Nick A. Guldemond, Bruno Vellas, H. Blain, P. Auge, O. Krys, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw - Poland-Faculté de Pharmacie de Paris, Institute of Neurobiology and Molecular Medicine, CNR, Rome, Italy and Department of Medicine-University of Naples Federico II, Institut d'Electronique du Solide et des Systèmes (InESS), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Departamento de Biología Molecular y Celular del Cáncer (CSIC-UAM), Instituto de Investigaciones Biomédicas A. Sols, Hôpital Lapeyronie [Montpellier] (CHU), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Equipe 3: EREN- Equipe de Recherche en Epidémiologie Nutritionnelle (CRESS - U1153), Université Paris 13 (UP13)-Institut National de la Recherche Agronomique (INRA)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université (HESAM)-HESAM Université (HESAM)-Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Neuropsychiatrie : recherche épidémiologique et clinique (PSNREC), Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Mécanismes moléculaires dans les démences neurodégénératives (MMDN), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société (CERMES3 - UMR 8211 / U988 / UM 7), École des hautes études en sciences sociales (EHESS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Gérontopôle, Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Toulouse [Toulouse], Université Paris-Est Marne-la-Vallée (UPEM), Université de Montpellier (UM), Euromov (EuroMov), Eindhoven University of Technology [Eindhoven] (TU/e), Laboratoire de Bioingénierie et NanoSciences (LBN), Département pneumologie et addictologie [Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Arnaud de Villeneuve, IMIM-Hospital del Mar, Generalitat de Catalunya, Groupe Matrice Extracellulaire et Biomineralisation, Université Paris Descartes - Paris 5 (UPD5), Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Astrophysique Interprétation Modélisation (AIM (UMR_7158 / UMR_E_9005 / UM_112)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut national des sciences de l'Univers (INSU - CNRS)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Julius Center for Health Sciences and Primary Care, University Medical Center [Utrecht], Service de Pneumologie, Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Cohortes épidémiologiques en population (CONSTANCES), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université Paris Cité (UPC), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université Montpellier 1 (UM1)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Université Paris 13 (UP13)-Institut National de la Recherche Agronomique (INRA)-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Université Montpellier 1 (UM1)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Montpellier (UM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut National de la Santé et de la Recherche Médicale (INSERM)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre National de la Recherche Scientifique (CNRS)-Institut national des sciences de l'Univers (INSU - CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Diderot - Paris 7 (UPD7), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université de Paris (UP), Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon ( MACVIA-LR ), Université Montpellier 1 ( UM1 ) -World Health Organization ( WHO/OMS ) -Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre Hospitalier Régional Universitaire de Nîmes ( CHRU Nîmes ) -Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ) -European Innovation Partnership on Active and Healthy Ageing Reference Site, Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] ( PhyMedExp ), Centre National de la Recherche Scientifique ( CNRS ) -Université de Montpellier ( UM ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Centre de pharmacologie et innovation dans le diabète ( CPID ), Université Montpellier 1 ( UM1 ) -Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Centre National de la Recherche Scientifique ( CNRS ), Medical University of Warsaw-Faculté de Pharmacie de Paris, CNR, Rome, Italy and Department of Medicine-Second University of Naples, Institut d'Electronique du Solide et des Systèmes ( InESS ), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique ( CNRS ), Departamento de Biología Molecular y Celular del Cáncer ( CSIC-UAM ), Hôpital Lapeyronie [Montpellier] ( CHU ), Equipe 3: EREN- Equipe de Recherche en Epidémiologie Nutritionnelle ( CRESS - U1153 ), Université Paris 13 ( UP13 ) -Institut National de la Recherche Agronomique ( INRA ) -Conservatoire National des Arts et Métiers [CNAM] ( CNAM ) -Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité ( CRESS (U1153 / UMR_A 1125) ), Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut National de la Recherche Agronomique ( INRA ) -Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Institut National de la Recherche Agronomique ( INRA ), Gerontopole of Toulouse, CHU- Université de Toulouse, Université Paris-Est Marne-la-Vallée ( UPEM ), Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ), Eindhoven University of Technology [Eindhoven] ( TU/e ), Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Arnaud de Villeneuve, Université Paris Descartes - Paris 5 ( UPD5 ), Institut de Recherche en Infectiologie de Montpellier ( IRIM ), Centre National de la Recherche Scientifique ( CNRS ) -Université de Montpellier ( UM ), Institut de génétique humaine ( IGH ), Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ), Laboratoire AIM, Université Paris Diderot - Paris 7 ( UPD7 ) -Centre d'Etudes de Saclay, Telecom Bretagne, Brest, Laboratoire de magnétisme et d'optique de Versailles ( LMOV ), Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ) -Centre National de la Recherche Scientifique ( CNRS ), Cognition, Action, et Plasticité Sensorimotrice [Dijon - U1093] ( CAPS ), Université de Bourgogne ( UB ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Departement de Cardiologie, Space Science Division, Neuropsychiatrie : recherche épidémiologique et clinique, Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Montpellier 1 ( UM1 ) -Université de Montpellier ( UM ), Université Paris-Sud - Paris 11 ( UP11 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Antoine Béclère, UMS11 Cohortes en population, Institut National de la Santé et de la Recherche Médicale ( INSERM ), Bousquet, J, Kuh, D, Bewick, M, Standberg, T, Farrell, J, Pengelly, R, Joel, M. E, Rodriguez Mañas, L, Mercier, J, Bringer, J, Camuzat, T, Bourret, R, Bedbrook, A, Kowalski, M. L, Samolinski, B, Bonini, S, Brayne, C, Michel, J. P, Venne, J, Viriot Durandal, P, Alonso, J, Avignon, A, Ben Shlomo, Y, Bousquet, P. J, Combe, B, Cooper, R, Hardy, R, Iaccarino, G, Keil, T, Kesse Guyot, E, Momas, I, Ritchie, K, Robine, J. M, Thijs, C, Tischer, C, Vellas, B, Zaidi, A, Alonso, F, Andersen Ranberg, K, Andreeva, V, Ankri, J, Arnavielhe, S, Arshad, H, Augé, P, Berr, C, Bertone, P, Blain, H, Blasimme, A, Buijs, G. J, Caimmi, D, Carriazo, A, Cesario, A, Coletta, J, Cosco, T, Criton, M, Cuisinier, F, Demoly, P, Fernandez Nocelo, S, Fougère, B, Garcia Aymerich, J, Goldberg, M, Guldemond, N, Gutter, Z, Harman, D, Hendry, A, Heve, D, Illario, Maddalena, Jeandel, C, Krauss Etschmann, S, Krys, O, Kula, D, Laune, D, Lehmann, S, Maier, D, Malva, J, Matignon, P, Melen, E, Mercier, G, Moda, G, Nizinkska, A, Nogues, M, O'Neill, M, Pelissier, J. Y, Poethig, D, Porta, D, Postma, D, Puisieux, F, Richards, M, Robalo Cordeiro, C, Romano, V, Roubille, F, Schulz, H, Scott, A, Senesse, P, Slagter, S, Smit, H. A, Somekh, D, Stafford, M, Suanzes, J, Todo Bom, A, Touchon, J, Traver Salcedo, V, Van Beurden, M, Varraso, R, Vergara, I, Villalba Mora, E, Wilson, N, Wouters, E, Zins, M., CNR, Rome, Italy and Department of Medicine-University of Naples Federico II = Università degli studi di Napoli Federico II, HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), École Pratique des Hautes Études (EPHE), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Astrophysique Interprétation Modélisation (AIM (UMR7158 / UMR_E_9005 / UM_112)), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université Paris Cité (UPCité), Bousquet, Jean, Kuh, D., Bewick, M., Standberg, T., Farrell, J., Pengelly, R., Joel, M. E., Rodriguez Mañas, L., Mercier, J., Bringer, J., Camuzat, T., Bourret, R., Bedbrook, A., Kowalski, M. L., Samolinski, B., Bonini, Sergio, Brayne, C., Michel, J. P., Venne, J., Viriot Durandal, P., Alonso, J., Avignon, A., Ben Shlomo, Y., Bousquet, P. J., Combe, B., Cooper, R., Hardy, R., Iaccarino, G., Keil, T., Kesse Guyot, E., Momas, I., Ritchie, K., Robine, J. M., Thijs, C., Tischer, C., Vellas, B., Zaidi, A., Alonso, F., Andersen Ranberg, K., Andreeva, V., Ankri, J., Arnavielhe, S., Arshad, H., Augé, P., Berr, C., Bertone, P., Blain, H., Blasimme, A., Buijs, G. J., Caimmi, D., Carriazo, A., Cesario, A., Coletta, J., Cosco, T., Criton, M., Cuisinier, F., Demoly, P., Fernandez Nocelo, S., Fougère, B., Garcia Aymerich, J., Goldberg, M., Guldemond, N., Gutter, Z., Harman, D., Hendry, A., Heve, D., Illario, M., Jeande, C., Krauss Etschmann, S., Krys, O., Kula, D., Laune, D., Lehmann, S., Maier, D., Malva, J., Matignon, P., Melen, E., Mercier, G., Moda, G., Nizinkska, A., Nogues, M., O’Neill, M., Pelissier, J. Y., Poethig, D., Porta, D., Postma, D., Puisieux, F., Richards, M., Robalo Cordeiro, C., Romano, V., Roubille, F., Schulz, H., Scott, A., Senesse, P., Slagter, S., Smit, H. A., Somekh, D., Stafford, M., Suanzes, J., Todo Bom, A., Touchon, J., Traver Salcedo, V., Van Beurden, M., Varraso, R., Vergara, I., Villalba Mora, E., Wilson, N., Wouters, E., Groningen Research Institute for Asthma and COPD (GRIAC), Epidemiologie, RS: CAPHRI School for Public Health and Primary Care, RS: CAPHRI - R5 - Optimising Patient Care, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nîmes (CHRU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université de Montpellier (UM)-École pratique des hautes études (EPHE), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Antoine Béclère, UMS011 Cohortes épidémiologiques en population (CONSTANCES), and Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Gerontology ,Aging ,media_common.quotation_subject ,[SDV]Life Sciences [q-bio] ,EUROPEAN INNOVATION PARTNERSHIP ,Population ,Medicine (miscellaneous) ,Social Environment ,MACVIA-LR ,Quality of life (healthcare) ,European Innovation Partnership on Active and Healthy Ageing ,Active and Healthy Ageing ,PREVENTING CHRONIC DISEASES ,definition ,Nutrition and Dietetics ,Geriatrics and Gerontology ,LIFE YEARS ,Nutrition and Dietetic ,Journal Article ,Medicine ,Humans ,DISEASES CHRONIC DISEASES ,Function (engineering) ,education ,Exercise ,ComputingMilieux_MISCELLANEOUS ,POPULATION ,media_common ,education.field_of_study ,[ SDV ] Life Sciences [q-bio] ,business.industry ,Operational definition ,EIP ,Social environment ,Conceptual framework ,Health ,General partnership ,Chronic Disease ,Quality of Life ,France ,Independent Living ,business ,Independent living ,Human ,macvia lr - Abstract
Health is a multi-dimensional concept, capturing how people feel and function. The broad concept of Active and Healthy Ageing was proposed by the World Health Organisation (WHO) as the process of optimizing opportunities for health to enhance quality of life as people age. It applies to both individuals and population groups. A universal Active and Healthy Ageing definition is not available and it may differ depending on the purpose of the definition and/or the questions raised. While the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) has had a major impact, a definition of Active and Healthy Ageing is urgently needed. A meeting was organised in Montpellier, France, October 20-21, 2014 as the annual conference of the EIP on AHA Reference Site MACVIA-LR (Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon) to propose an operational definition of Active and Healthy Ageing including tools that may be used for this. The current paper describes the rationale and the process by which the aims of the meeting will be reached. Health is a multi-dimensional concept, capturing how people feel and function. The broad concept of Active and Healthy Ageing was proposed by the World Health Organisation (WHO) as the process of optimizing opportunities for health to enhance quality of life as people age. It applies to both individuals and population groups. A universal Active and Healthy Ageing definition is not available and it may differ depending on the purpose of the definition and/or the questions raised. While the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) has had a major impact, a definition of Active and Healthy Ageing is urgently needed. A meeting was organised in Montpellier, France, October 20-21, 2014 as the annual conference of the EIP on AHA Reference Site MACVIA-LR (Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon) to propose an operational definition of Active and Healthy Ageing including tools that may be used for this. The current paper describes the rationale and the process by which the aims of the meeting will be reached.
- Published
- 2015
- Full Text
- View/download PDF
26. Effect of automated drug distribution systems on medication error rates in a short-stay geriatric unit
- Author
-
Pascal Odou, Antoine Caillau, Patrick Coupé, Jean-Paul Bonte, Julie Mareville, Bertrand Décaudin, Etienne Cousein, François Puisieux, Delphine Dambre, Julien Labreuche, and Alexandre Lerooy
- Subjects
Clinical audit ,Male ,medicine.medical_specialty ,Medication Systems, Hospital ,elderly ,Medication error ,Automation ,medical order entry systems ,medicine ,Humans ,General hospital ,Intensive care medicine ,Aged ,Quality of Health Care ,Geriatrics ,robotics ,Aged, 80 and over ,Wrong drug ,business.industry ,Health Policy ,clinical audit ,Public Health, Environmental and Occupational Health ,drug distribution system ,Medication administration ,Original Articles ,medication errors ,Short stay ,Emergency medicine ,Observational study ,Female ,France ,business - Abstract
Rationale, aims and objectives To assess the impact of an automated drug distribution system on medication errors (MEs). Methods Before-after observational study in a 40-bed short stay geriatric unit within a 1800 bed general hospital in Valenciennes, France. Researchers attended nurse medication administration rounds and compared administered to prescribed drugs, before and after the drug distribution system changed from a ward stock system (WSS) to a unit dose dispensing system (UDDS), integrating a unit dose dispensing robot and automated medication dispensing cabinet (AMDC). Results A total of 615 opportunities of errors (OEs) were observed among 148 patients treated during the WSS period, and 783 OEs were observed among 166 patients treated during the UDDS period. ME [medication administration error (MAE)] rates were calculated and compared between the two periods. Secondary measures included type of errors, seriousness of errors and risk reduction for the patients. The implementation of an automated drug dispensing system resulted in a 53% reduction in MAEs. All error types were reduced in the UDDS period compared with the WSS period (P
- Published
- 2014
27. Correction to: Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital’s Fracture Liaison Service between January 2016 and January 2018
- Author
-
Bernard Cortet, François Puisieux, Julien Paccou, A Gournay, Isabelle Delabriere, Arnaud Pflimlin, and Christophe Chantelot
- Subjects
0301 basic medicine ,Secondary prevention ,Service (business) ,business.industry ,Endocrinology, Diabetes and Metabolism ,Published Erratum ,MEDLINE ,030209 endocrinology & metabolism ,University hospital ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,030101 anatomy & morphology ,Medical emergency ,business - Abstract
The original version of this article, published on 5 June 2019, an author's name was misspelled.
- Published
- 2019
- Full Text
- View/download PDF
28. Post-fall syndrome: Profile and outcomes
- Author
-
François Puisieux, Florence Beaucamp, Philippe Chassagne, Frédéric Roca, André Thevenon, and Charlotte Mathon
- Subjects
medicine.medical_specialty ,business.industry ,Rehabilitation ,Osteoporosis ,Falls in older adults ,medicine.disease ,Gait ,Fear of falling ,Interquartile range ,Internal medicine ,medicine ,Physical therapy ,Hypertonia ,Anxiety ,Orthopedics and Sports Medicine ,medicine.symptom ,Vascular dementia ,business - Abstract
Objective Post-fall syndrome (PFS) is a severe complication of falls in older adults. PFS is considered to be a medical emergency in geriatric patients, given the risk of a decompensatory “domino effect” and mortality. Unfortunately, there is currently no consensus on how to detect patients at risk of PFS. The primary objective of the present study was to profile patients suffering from PFS. The secondary objective was to study the prognosis of patients with PFS after their discharge from an aftercare and rehabilitation department (ARD). Material/Patients and methods We prospectively surveyed patients hospitalized in the geriatric ARD at Lille University Hospital (Lille, France) after a fall. Cases (i.e. patients meeting the criteria for PFS: the simultaneous presence of a postural disorder, a gait disorder and a psychobehavioural disorder) were compared with controls (i.e. patients free of PFS). Results Seventy-two patients were included (females: 74%). The median [interquartile range] age was 85.5 [81; 90]. Thirty-four patients (47%) had PFS. The symptoms most frequent significantly associated with PFS were retropulsion in stance, and anxiety about movement. Cases and controls did not differ significantly with regard to other signs (little step walking, axial akinesia, oppositional hypertonia, etc.). Patients with PFS were more likely to present with vascular dementia (P = 0.0166) and osteoporosis (P = 0.0458), and were less likely to be taking drugs associated with falls (P = 0.0003). Initial functional assessments (according to both the Mini Motor Test and the Timed Up-and-Go test) showed that functional abilities were more severely impaired in the patients suffering from PFS. Nevertheless, the same functional assessment on discharge did not reveal a significant difference between the two groups. Likewise, there were no intergroup differences in mortality or institutionalization on discharge from the ARD. Discussion/Conclusion The imperative development of a precise, consensual definition of PFS is now justified by the gravity of this syndrome and the potential for functional recovery. Continuation of this ongoing study may highlight prognostic factors associated with the status of patients with PFS 6 months after discharge from the ARD.
- Published
- 2017
- Full Text
- View/download PDF
29. Fear of falling as seen in the Multidisciplinary falls consultation
- Author
-
Isabelle Delabriere, V. Pardessus, F. Chourabi, T. Nguyen, André Thevenon, François Puisieux, Julia Salleron, and C. Gaxatte
- Subjects
Male ,Risk ,medicine.medical_specialty ,Poison control ,Fear of falling ,Activity restriction ,Suicide prevention ,Vulnerable Populations ,Occupational safety and health ,Restriction d’activité ,Elderly ,Injury prevention ,Fall ,Chute ,Medicine ,Humans ,Orthopedics and Sports Medicine ,Prospective Studies ,Postural Balance ,Aged ,Geriatrics ,Aged, 80 and over ,business.industry ,Rehabilitation ,Human factors and ergonomics ,Fear ,Physical and Rehabilitation Medicine ,Falling (accident) ,Neurology ,Peur de tomber ,Sensation Disorders ,Physical therapy ,Accidental Falls ,Female ,Interdisciplinary Communication ,Homebound Persons ,medicine.symptom ,business ,Sujet âgé - Abstract
Fear of falling may be as debilitating as the fall itself, leading to a restriction in activities and even a loss of autonomy.ObjectivesThe main objective was to evaluate the prevalence of the fear of falling among elderly fallers. The secondary objectives were to determine the factors associated with the fear of falling and evaluate the impact of this fear on the activity “getting out of the house”.Patients and methodProspective study conducted between 1995 and 2006 in which fallers and patients at high risk for falling were seen at baseline by the multidisciplinary falls consultation team (including a geriatrician, a neurologist and a physical medicine and rehabilitation physician) and then, again 6 month later, by the same geriatrician. The fear of falling was evaluated with a yes/no question: “are you afraid of falling?”.ResultsOut of 635 patients with a mean age of 80.6 years, 502 patients (78%) expressed a fear of falling. Patients with fear of falling were not older than those who did not report this fear, but the former were mostly women (P
- Published
- 2011
- Full Text
- View/download PDF
30. Impact of different types of walking aids on the physiological energy cost during gait for elderly individuals with several pathologies and dependent on a technical aid for walking
- Author
-
François Puisieux, V. Pardessus, J. Muzembo, André Thevenon, and E. Cetin
- Subjects
Male ,medicine.medical_specialty ,Population ,Aide à la marche ,Walking ,Walkers ,Elderly ,Walking aid ,Acquired immunodeficiency syndrome (AIDS) ,Heart Rate ,Heart rate ,Personne âgée ,medicine ,Humans ,Orthopedics and Sports Medicine ,education ,Gait ,Aged ,Aged, 80 and over ,Geriatrics ,education.field_of_study ,business.industry ,Rehabilitation ,Muscle weakness ,medicine.disease ,Cardiac frequency ,Test (assessment) ,Preferred walking speed ,Physical therapy ,Fréquence cardiaque ,Female ,medicine.symptom ,Energy Metabolism ,business ,human activities - Abstract
In elderly individuals balance disorders and muscle weakness can lead to prescribing a walker. There are several different models. According to the very poor effort tolerance in this population, the energy cost necessary to operate walking technical aids should be taken into account when making a choice.ObjectiveCompare two types of walker in regards to energy cost produced during gait in weakened elderly individuals.MethodThirty subjects over the age of 65 (six men and 24 women, mean age 81.9 years) were admitted in geriatrics care. They all required a walker and performed the same 10-m course with a fixed walker, then with a model bearing front wheels. The walking speed (S) was computed, heart rate at rest (HRrest) and maximum heart rate (HRmax) were recorded during the test. The physiological cost index (PCI=HRmax−HRrest/S) was calculated. Finally a timed get-up-and-go (TGUG) test was performed with each of these technical aids.ResultsWith a rollator walker, HRmax was lower (P
- Published
- 2010
- Full Text
- View/download PDF
31. Functional decline in elderly patients presenting with acute coronary syndromes: Impact on midterm outcome
- Author
-
Pierre-Vladimir Ennezat, Jean-Luc Auffray, François Puisieux, Frédéric Mouquet, Patrick Goldstein, Clémence Huerre, Sylvestre Maréchaux, Jean-Jacques Bauchart, Martine Lesenne, Aurélie Guiot, Philippe Asseman, and David Montaigne
- Subjects
Male ,medicine.medical_specialty ,Acute coronary syndrome ,Time Factors ,Health Services for the Aged ,Comorbidity ,Risk Assessment ,Disease-Free Survival ,Angina ,Risk Factors ,Internal medicine ,Activities of Daily Living ,medicine ,Humans ,Angina, Unstable ,Prospective Studies ,Myocardial infarction ,Acute Coronary Syndrome ,Prospective cohort study ,Geriatric Assessment ,Aged ,Proportional Hazards Models ,Killip class ,Aged, 80 and over ,Chi-Square Distribution ,business.industry ,Unstable angina ,Hazard ratio ,Age Factors ,General Medicine ,medicine.disease ,Surgery ,Treatment Outcome ,Disease Progression ,Female ,France ,Independent Living ,Cardiology and Cardiovascular Medicine ,business - Abstract
Summary Background Elderly patients with an acute coronary syndrome (ACS) are less likely to be enrolled into randomized, controlled trials or receive guideline-recommended therapies, because of a higher burden of comorbidity, including functional decline. Aim To assess the prognostic value of functional decline in a prospective, observational cohort of elderly ACS patients. Methods ACS patients aged ≥ 70 years were enrolled. The ACS definition included ST- and non-ST-segment elevation myocardial infarction, and unstable angina pectoris. Clinical admission and laboratory data and echocardiographic variables were recorded. Functional decline was defined as needing assisted care in daily life. The study endpoint was all-cause mortality. Results Overall, 151 patients were enrolled (mean age 78 ± 5 years; 52% men). Twenty-eight (19%) patients had functional decline. No significant difference in therapeutic management was observed between patients with functional decline and those living independently. Twenty-seven (18%) patients died during follow-up (median 447 days). Functional decline correlated with poor outcome ( p = 0.008; hazard ratio [HR] 2.87 [1.31–6.25]). Other prognostic markers were diabetes, Killip class ≥ II, elevated E/Ea ratio, C-reactive protein, B-type natriuretic peptide, haemoglobin, glycaemia and no coronary angiography. By multivariable analysis, C-reactive protein > 13 mg/L correlated with poor outcome ( p = 0.007; HR 4.77 [1.52–14.96]). There was a trend towards correlation between functional decline and poor outcome ( p = 0.051; HR = 2.77 [0.99–7.72]). Conclusion Functional decline seems to portend poor prognosis in elderly ACS patients. Larger, community-based studies are needed to confirm these findings in a multivariable model.
- Published
- 2010
- Full Text
- View/download PDF
32. Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015
- Author
-
Karen Ritchie, Daniel Harman, Philippe-Jean Bousquet, Erik Melén, Pierre Senesse, Govert Joan Buijs, Antonio Cano, Claude Jeandel, Timo E. Strandberg, Marieke Van Beurden, Pascal Demoly, G. Moda, Raquel Santiago, Sylvie Arnavielhe, Marie-Eve Joel, Nicola Wilson, Eveline Wouters, Jacques Touchon, Martina O'Neill, Isabelle Momas, Karen Andersen Ranberg, D. Heve, Maddalena Illario, Christina Tischer, Jean Bousquet, Marcel Goldberg, Paola Bertone, Guido Iaccarino, Antoine Avignon, Rodolphe Bourret, Valeria Romano, Laura Calzà, Henriet A. Smit, Mirca Barbolini, David Kula, Jacques-Yves Pelissier, Mario Barbagallo, Bruno Vellas, Ann Scott, C. Robalo-Cordeiro, Gregoire Mercier, Mike Bewick, Bernard Combe, Holger Schulz, Sergio Bonini, P. Viriot-Durandal, Itziar Vergara, M. Nogues, Carol Brayne, João Apóstolo, Jacques Mercier, Vicente Traver-Salcedo, François Puisieux, Julia Coletta, Alessandro Blasimme, Olivier Krys, Niels H. Chavannes, John Farrell, Joël Ankri, Ana Maria Carriazo, Rafaelle Varraso, Marie Zins, Zdenec Gutter, José António Pereira da Silva, Bertrand Fougère, Frédéric Cuisinier, Bolesław Samoliński, Jacques Bringer, Theodore D. Cosco, Jordi Alonso, Ana Todo-Bom, Claudine Berr, Daniel Laune, Esteban De Manuel Keenoy, Judith Garcia-Aymerich, Anna Bedbrook, Anne Hendry, Richard Pengelly, Dagmar Poethig, João O. Malva, Thomas Keil, Sandra N. Slagter, Nick A. Guldemond, Pierre Matignon, Hubert Blain, Leocadio Rodríguez Mañas, Marek L. Kowalski, Susana Fernandez-Nocelo, Alfredo Cesario, Sandra Rebello, Federico Alonso, Catarina R. Oliveira, Dieter Maier, Jean-Pierre Michel, David Somekh, T. Camuzat, Julien Venne, Marc Criton, Jaime Correia de Sousa, Hassan Arshad, Anabella Mota Pinto, Valentina A. Andreeva, François Roubille, Yoav Ben-Shlomo, Asghar Zaidi, Elena Villalba-Mora, Emmanuelle Kesse-Guyot, Dirkje S. Postma, Carel Thijs, Jean-Marie Robine, Danielle Porta, George Crooks, Adrianna Nizinska, Jorge Suanzes, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Bone and Joint Research Group, University of Southampton Medical School, CHU Toulouse [Toulouse], Center for Research in Environmental Epidemiology (CREAL), Universitat Pompeu Fabra [Barcelona] (UPF)-Catalunya ministerio de salud, Santé publique et épidémiologie des déterminants professionnels et sociaux de la santé, Epidémiologie, sciences sociales, santé publique (IFR 69), Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Department of Social Medicine, University of Bristol [Bristol], Pathologies du système nerveux : recherche épidémiologique et clinique, Université Montpellier 1 (UM1)-IFR76-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Electrical Engineering, Mathematics and Computer Science [Delft], Delft University of Technology (TU Delft), Unité de Recherche en Epidémiologie Nutritionnelle (UREN), Université Paris 13 (UP13)-Institut National de la Recherche Agronomique (INRA)-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), F2ME, PSA Peugeot - Citroën (PSA), PSA Peugeot Citroën (PSA)-PSA Peugeot Citroën (PSA)-Laboratoire Pluridisciplinaire de Recherche en Ingénierie des Systèmes, Mécanique et Energétique (PRISME), Université d'Orléans (UO)-Ecole Nationale Supérieure d'Ingénieurs de Bourges (ENSI Bourges)-Université d'Orléans (UO)-Ecole Nationale Supérieure d'Ingénieurs de Bourges (ENSI Bourges), Department of Epidemiology and Public Health, Imperial College London, CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société (CERMES3 - UMR 8211 / U988 / UM 7), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-École des hautes études en sciences sociales (EHESS), Département Ecologie, Physiologie et Ethologie (DEPE-IPHC), Institut Pluridisciplinaire Hubert Curien (IPHC), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS)-Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw - Poland, Department of Epidemiology, Maastricht University [Maastricht]-School for Public Health and Primary Care (CAPHRI), Hôpital Gui de Chauliac, Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Institut National de la Recherche Agronomique (INRA)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Kyomed, Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Department of Geriatrics - Efficiency and Deficiency Laboratory, Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Consiglio Nazionale delle Ricerche (CNR), Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Département pneumologie et addictologie [Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Arnaud de Villeneuve, Department of Public Health and Primary Care, University of Cambridge [UK] (CAM), Service d'endocrinologie, Departamento de Sistemas Informáticos y Computación [Valencia], Universitat Politècnica de València (UPV), Deputy Scientific Director, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Pisana, Département de Rhumatologie[Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie, Laboratoire de chimie biomoléculaire (LCB), Université Montpellier 2 - Sciences et Techniques (UM2)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-MAYOLI SPINDLER SA-Centre National de la Recherche Scientifique (CNRS), Laboratoire de Bioingénierie et NanoSciences (LBN), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Laboratoire de Gérontechnologie [Hôpital La Grave-CHU de Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Gérontopôle, IMIM-Hospital del Mar, Generalitat de Catalunya, Département de Biostatistiques, Agence Régionale de Santé Languedoc Roussillon (ARS), Department of Medicine and Surgery, Università degli Studi di Salerno (UNISA)-RCCS 'Multimedia', Centre de gérontologie clinique, Institute of Social Medicine, Epidemiology and Health Economics-Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institute of Environmental Medicine, Karolinska Institutet [Stockholm]-Karolinska University Hospital [Stockholm]-Astrid Lindgren Children's Hospital, Lab-STICC_TB_CID_TOMS, Laboratoire des sciences et techniques de l'information, de la communication et de la connaissance (Lab-STICC), École Nationale d'Ingénieurs de Brest (ENIB)-Université de Bretagne Sud (UBS)-Université de Brest (UBO)-Télécom Bretagne-Institut Brestois du Numérique et des Mathématiques (IBNM), Université de Brest (UBO)-Université européenne de Bretagne - European University of Brittany (UEB)-École Nationale Supérieure de Techniques Avancées Bretagne (ENSTA Bretagne)-Institut Mines-Télécom [Paris] (IMT)-Centre National de la Recherche Scientifique (CNRS)-École Nationale d'Ingénieurs de Brest (ENIB)-Université de Bretagne Sud (UBS)-Université de Brest (UBO)-Télécom Bretagne-Institut Brestois du Numérique et des Mathématiques (IBNM), Université de Brest (UBO)-Université européenne de Bretagne - European University of Brittany (UEB)-École Nationale Supérieure de Techniques Avancées Bretagne (ENSTA Bretagne)-Institut Mines-Télécom [Paris] (IMT)-Centre National de la Recherche Scientifique (CNRS), Epidémiologie Environnementale : Impact Sanitaire des Pollutions (EA 4064), Université Paris Descartes - Paris 5 (UPD5), Universidad Pública de Navarra [Espagne] = Public University of Navarra (UPNA), Unité de Virologie clinique et fondamentale (UVCF), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, Mécanismes adaptatifs : des organismes aux communautés (MAOAC), Muséum national d'Histoire naturelle (MNHN)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Department of Pulmonary Medicine and Tuberculosis, University of Groningen [Groningen], Service de gériatrie, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Allergy and Clinical Immunology Department, Hospitais da Universidade de Coimbra, Département de nutrition et d'oncologie digestive, CRLCC Val d'Aurelle - Paul Lamarque, Institute of Epidemiology [Neuherberg] (EPI), German Research Center for Environmental Health - Helmholtz Center München (GmbH), Centre de recherche en épidémiologie et santé des populations (CESP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Bousquet, Jean, Malva, Joao, Nogues, Michel, Mañas, Leocadio Rodriguez, Vellas, Bruno, Farrell, J, Bewick, M, Kowalski, Ml, Strandberg, T, Alonso, J, Ranberg, Ka, Ankri, J, Barbagallo, M, Ben Shlomo, Y, Berr, C, Crooks, G, de Manuel Keenoy, E, Goldberg, M, Guldemond, N, Illario, Maddalena, Joel, Me, Kesse Guyot, E, Michel, Jp, Pengelly, R, Ritchie, K, Robine, Jm, Romano, V, Samolinski, B, Schulz, H, Thijs, C, Touchon, J, Zaidi, A, Apostolo, J, Alonso, F, Andreeva, V, Arnavielhe, S, Arshad, H, Avignon, A, Barbolini, M, Bedbrook, A, Bertone, P, Blain, H, Blasimme, A, Bonini, S, Bourret, R, Bousquet, Pj, Brayne, C, Bringer, J, Buijs, Gj, Calza, L, Camuzat, T, Cano, A, Carriazo, A, Cesario, A, Chavannes, N, Combe, B, Coletta, J, de Sousa, Jc, Cosco, T, Criton, M, Cuisinier, F, Demoly, P, Fernandez Nocelo, S, Fougère, B, Garcia Aymerich, J, Gutter, Z, Harman, D, Hendry, A, Hève, D, Iaccarino, G, Jeandel, C, Keil, T, Krys, O, Kula, D, Laune, D, Maier, D, Matignon, P, Melen, E, Mercier, G, Moda, G, Momas, I, Pinto, Am, Nizinska, A, Oliveira, C, O'Neill, M, Pelissier, Jy, Pereira da Silva, Ja, Poethig, D, Porta, D, Postma, D, Puisieux, F, Rebello, S, Robalo Cordeiro, C, Roubille, F, Santiago, R, Scott, A, Senesse, P, Slagter, S, Smit, Ha, Somekh, D, Suanzes, J, Tischer, C, Todo Bom, A, Traver Salcedo, V, Van Beurden, M, Varraso, R, Venne, J, Vergara, I, Villalba Mora, E, Viriot Durandal, P, Wilson, N, Wouters, E, Zins, M, Mercier, J., Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nîmes (CHRU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Universitat Pompeu Fabra [Barcelona]-Catalunya ministerio de salud, Université Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Sorbonne Paris Cité (USPC)-Université Paris 13 (UP13)-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Institut National de la Recherche Agronomique (INRA), Ecole Nationale Supérieure d'Ingénieurs de Bourges (ENSI Bourges)-Université d'Orléans (UO)-Ecole Nationale Supérieure d'Ingénieurs de Bourges (ENSI Bourges)-Université d'Orléans (UO), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de la Recherche Agronomique (INRA)-Université Paris Descartes - Paris 5 (UPD5)-Université Sorbonne Paris Cité (USPC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), CHU Montpellier, Universidad Politécnica de Valencia, Centre National de la Recherche Scientifique (CNRS)-MAYOLI SPINDLER SA-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Université Montpellier 2 - Sciences et Techniques (UM2), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Gérontopôle-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Toulouse [Toulouse], University of Salerno (UNISA)-RCCS 'Multimedia', Charité - Universitätsmedizin Berlin / Charite - University Medicine Berlin -Epidemiology and Health Economics, Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Universidad Pública de Navarra [Espagne] (UPNA), Unité de Virologie clinique et fondamentale EA 4294, Centre National de la Recherche Scientifique (CNRS)-Collège de France (CdF)-Muséum national d'Histoire naturelle (MNHN), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Bousquet J, Malva J, Nogues M, Mañas LR, Vellas B, Farrell J, MACVIA Research Group [.., L. Calzà, ], Farrell, John, Bonini, Sergio, Université Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Muséum national d'Histoire naturelle (MNHN)-Collège de France (CdF)-Centre National de la Recherche Scientifique (CNRS), Epidemiologie, RS: CAPHRI School for Public Health and Primary Care, and RS: CAPHRI - R5 - Optimising Patient Care
- Subjects
Gerontology ,Concept Formation ,[SDV]Life Sciences [q-bio] ,Disability Evaluation ,0302 clinical medicine ,SF-12 ,QUALITY-OF-LIFE ,Surveys and Questionnaires ,WHODAS 2.0 ,Medicine ,030212 general & internal medicine ,VERSION ,POPULATION ,PSYCHOLOGICAL DISTRESS ,SCALE ,General Nursing ,Nursing (all)2901 Nursing (miscellaneous) ,health care economics and organizations ,ComputingMilieux_MISCELLANEOUS ,Aged, 80 and over ,education.field_of_study ,Operational definition ,Medicine (all) ,Health Policy ,PHYSICAL-ACTIVITY QUESTIONNAIRE ,PRIMARY-CARE ,General Medicine ,3. Good health ,Europe ,General partnership ,Scale (social sciences) ,Population ,SELF-REPORT ,VALIDATION ,03 medical and health sciences ,Quality of life (healthcare) ,EQ-5D ,Journal Article ,Humans ,OLDER-ADULTS ,education ,Geriatric Assessment ,Health policy ,Aged ,business.industry ,questionnaire ,Active and healthy ageing ,United States ,Questionnaire ,Quality of Life ,The Conceptual Framework ,Geriatrics and Gerontology ,business ,030217 neurology & neurosurgery ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
A core operational definition of active and healthy aging (AHA) is needed to conduct comparisons. A conceptual AHA framework proposed by the European Innovation Partnership on Active and Healthy Ageing Reference Site Network includes several items such as functioning (individual capability and underlying body systems), well-being, activities and participation, and diseases (including non-communicable diseases, frailty, mental and oral health disorders). The instruments proposed to assess the conceptual framework of AHA have common applicability and availability attributes. The approach includes core and optional domains/instruments depending on the needs and the questions. A major common domain is function, as measured by the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). WHODAS 2.0 can be used across all diseases and healthy individuals. It covers many of the AHA dimensions proposed by the Reference Site network. However, WHODAS 2.0 does not include all dimensions proposed for AHA assessment. The second common domain is health-related quality of life (HRQoL). A report of the AHA questionnaire in the form of a spider net has been proposed to facilitate usual comparisons across individuals and groups of interest. (C) 2015 Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.
- Published
- 2015
- Full Text
- View/download PDF
33. Acrylamide induces accelerated endothelial aging in a human cell model
- Author
-
Rodrigo Lorenzi, Cyril Sellier, Eric Boulanger, Pierre Desreumaux, Nicolas Grossin, François Puisieux, Remi Neviere, Frédéric J. Tessier, Jean-Baptiste Beuscart, François Maladry, Lille Inflammation Research International Center (LIRIC), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Expression de Gènes et régulation Epigénétique par l'ALiment (EGEAL), Institut Polytechnique LaSalle Beauvais, Santé publique : épidémiologie et qualité des soins-EA 2694 (CERIM), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille, Pôle de gérontologie [CHRU de Lille], Hôpital Roger Salengro-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), This study was supported by the GLYCACHIC Program (Nord-Pas de Calais and Picardie Regions 2011_00202/00219-00221 and European Union 2011_00190/00198-00199) with additional assistance provided by the Nutrition-Health-Longevity (Nutrition-Santé-Longévité) Cluster (Lille, France). The authors are also grateful to Lille Métropole Communauté Urbaine and to Digestscience Foundation for financial support., Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Lille Inflammation Research International Center - U 995 (LIRIC), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Hôpital Roger Salengro [Lille]-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Institut Pasteur de Lille, and Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)
- Subjects
[SDV]Life Sciences [q-bio] ,Apoptosis ,MESH: Epoxy Compounds/metabolism ,MESH: Acrylamide/metabolism ,Toxicology ,MESH: Acrylamide/toxicity ,Umbilical vein ,0302 clinical medicine ,MESH: Osmolar Concentration ,MESH: Cell Proliferation/drug effects ,Endothelial cell ,MESH: Epoxy Compounds/toxicity ,MESH: Telomere Shortening/drug effects ,MESH: Carcinogens/metabolism ,Hayflick's limit ,Cells, Cultured ,Cellular Senescence ,Telomere Shortening ,0303 health sciences ,Acrylamide ,Chemistry ,MESH: Carcinogens/toxicity ,General Medicine ,Endothelial stem cell ,medicine.anatomical_structure ,Biochemistry ,MESH: Endothelium, Vascular/metabolism ,030220 oncology & carcinogenesis ,Cell aging ,MESH: Cells, Cultured ,Senescence ,Telomere length shortening ,MESH: Apoptosis/drug effects ,Endothelium ,MESH: Endothelium, Vascular/cytology ,Cell Survival ,MESH: Maillard Reaction ,MESH: Toxicity Tests, Subchronic ,03 medical and health sciences ,parasitic diseases ,Human Umbilical Vein Endothelial Cells ,medicine ,Humans ,Cell Proliferation ,030304 developmental biology ,MESH: Humans ,Cell growth ,MESH: Endothelium, Vascular/drug effects ,MESH: Biomarkers/metabolism ,Osmolar Concentration ,Toxicity Tests, Subchronic ,beta-Galactosidase ,Molecular biology ,Maillard Reaction ,Telomere ,MESH: Human Umbilical Vein Endothelial Cells/cytology ,Carcinogens ,Epoxy Compounds ,MESH: Cellular Senescence/drug effects ,Endothelium, Vascular ,MESH: beta-Galactosidase/metabolism ,MESH: Cell Survival/drug effects ,Biomarkers ,Food Science - Abstract
International audience; Acrylamide (AAM) has been recently discovered in food as a Maillard reaction product. AAM and glycidamide (GA), its metabolite, have been described as probably carcinogenic to humans. It is widely established that senescence and carcinogenicity are closely related. In vitro, endothelial aging is characterized by replicative senescence in which primary cells in culture lose their ability to divide. Our objective was to assess the effects of AAM and GA on human endothelial cell senescence. Human umbilical vein endothelial cells (HUVECs) cultured in vitro were used as model. HUVECs were cultured over 3 months with AAM or GA (1, 10 or 100 μM) until growth arrest. To analyze senescence, β-galactosidase activity and telomere length of HUVECs were measured by cytometry and semi-quantitative PCR, respectively. At all tested concentrations, AAM or GA reduced cell population doubling compared to the control condition (p < 0.001). β-galactosidase activity in endothelial cells was increased when exposed to AAM (≥10 μM) or GA (≥1 μM) (p < 0.05). AAM (≥10 μM) or GA (100 μM) accelerated telomere shortening in HUVECs (p < 0.05). In conclusion, in vitro chronic exposure to AAM or GA at low concentrations induces accelerated senescence. This result suggests that an exposure to AAM might contribute to endothelial aging.At all tested concentrations, AAM or GA reduced cell population doubling compared to the control condition (p < 0.001). β-galactosidase activity in endothelial cells was increased when exposed to AAM (≥10 μM) or GA (≥1 μM) (p < 0.05). AAM (≥10 μM) or GA (100 μM) accelerated telomere shortening in HUVECs (p < 0.05).In conclusion, in vitro chronic exposure to AAM or GA at low concentrations induces accelerated senescence. This result suggests that an exposure to AAM might contribute to endothelial aging.
- Published
- 2015
- Full Text
- View/download PDF
34. Private practice-hospital patient pathways for elderly people with falls or at risk of falls: A study in Lille (northern France)
- Author
-
Jean-Pierre Marissal, Florence Beaucamp, Bruno Pollez, V. Pardessus, André Thevenon, and François Puisieux
- Subjects
education.field_of_study ,Rehabilitation ,business.industry ,medicine.medical_treatment ,Population ,Poison control ,medicine.disease ,Suicide prevention ,Occupational safety and health ,Private practice ,medicine ,Orthopedics and Sports Medicine ,Medical emergency ,education ,business ,Fall prevention ,Patient education - Abstract
Opinion/feedback Private practice-hospital patient pathways for elderly people with falls or at risk of falls: a study in Lille (northern France). About a third of the over-65 population will fall at least once a year. In France, falls are responsible for more than 9000 deaths among the over-65s and constitute a frequent reason for admission to long-stay care establishments [1] . Many different factors are involved in falls, which prompts the need for multidisciplinary assessments. For the last 15 years, Lille University Medical Centre (Lille, northern France) has been running multidisciplinary assessments at its day hospital for elderly people who have fallen or are at risk of falling. The patients’ medical, rehabilitational and retraining needs are identified during their admission to the day hospital. In 2013, the day hospital and the Lille urban area's existing private-practice care networks (e.g. physiotherapy) were completed by a number of innovative care systems: a care network for fall prevention and home-based rehabilitation (“ESPRAD Chute”), patient education workshops on falls, and a day hospital for follow-up care and geriatric retraining (“HDJ SSR Geriatrique”). The ESPRAD Chute network is based on nurse-led homecare and provides the patient with 15 home-based therapy sessions that complement surgery-based care. Patient education is based on 12 weekly sessions for elderly fallers. The HDJ SSR Geriatrie day hospital provides multidisciplinary rehabilitation for fallers or people at risk of falls and who require intensive rehabilitation and retraining. The interface between the day hospital and existing care structures enabled us to create private practice-hospital pathways for the multidisciplinary management of elderly people at risk of falls. We present our experience of these patient pathways and the associated care systems.
- Published
- 2016
- Full Text
- View/download PDF
35. Bon usage des médicaments chez le sujet âgé
- Author
-
M. Villiet, Jean-Marc Davy, A. Terminet, L Ayach, P Hemmi, P Rambourg, B Millat, A Blain, B. Combe, I Roch-Torreilles, B. Celton, Hubert Blain, R Thuret, Xavier Quantin, J. Ribstein, Georges Mourad, Jean Bousquet, Christian Geny, Isabelle Quéré, D Rosant, Rodolphe Bourret, Michael Bismuth, François Puisieux, M. Léglise, Florence Leclercq, N Deshormières, A. Le Quellec, Dominique Hillaire-Buys, A. Jalabert, Boris Jung, Eric Renard, P Biboulet, Yves Rolland, Olivier Jonquet, Groupe de travail Chu de Montpellier – Macvia-Lr, Jacques Morel, Y Dauvilliers, J –P Boulenger, MP Ponrouch, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR), Université Montpellier 1 (UM1)-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-European Innovation Partnership on Active and Healthy Ageing Reference Site (EIP on AHA), Commission Européenne-Commission Européenne-Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Hôpital Lapeyronie [Montpellier] (CHU), Caractéristiques féminines des dysfonctions des interfaces cardio-vasculaires (EA 2992), Université Montpellier 1 (UM1)-Université de Montpellier (UM), Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Groupe de travail CHU de Montpellier – MACVIA-LR, MORNET, Dominique, Euromov (EuroMov), Université de Montpellier (UM), Pôle Digestif [CHRU Montpellier], Département de psychiatrie adulte, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital La Colombière, Institut des Neurosciences de Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Service de Biopathologie [CHRU Montpellier], Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Université Toulouse III - Paul Sabatier (UT3), and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
medicine.medical_specialty ,Age categories ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Drug adverse effect ,Daily practice ,Internal Medicine ,medicine ,Effet indésirable médicamenteux ,030212 general & internal medicine ,Adverse effect ,[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology ,business.industry ,[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology ,Gastroenterology ,Potentially Inappropriate Medications ,3. Good health ,Family medicine ,Relative risk ,[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology ,Drug ,Older people ,business ,Sujet âgé ,Médicament - Abstract
Drug-induced adverse effects are one of the main avoidable causes of hospitalization in older people. Numerous lists of potentially inappropriate medications for older people have been published, as national and international guidelines for appropriate prescribing in numerous diseases and for different age categories. The present review describes the general rules for an appropriate prescribing in older people and summarizes, for the main conditions encountered in older people, medications that are too often under-prescribed, the precautions of use of the main drugs that induce adverse effects, and drugs for which the benefit to risk ratio is unfavourable in older people. All these data are assembled in educational tables designed to be printed in a practical pocket format and used in daily practice by prescribers, whether physicians, surgeons or pharmacists., Les effets indésirables médicamenteux représentent l'une des principales causes évitables d'hospitalisation chez les sujets âgés. Un certain nombre de listes de médicaments potentielle-ment inappropriés chez les sujets âgés a été publié et il existe de nombreuses recommandations internationales pour le bon usage des médicaments par pathologie, et par tranche d'âge. La présente mise au point précise les règles générales de prescription des médicaments chez les sujets âgés et résume, pour les situations cliniques les plus fréquemment rencontrées, les médicaments sous-utilisés à tort et à recommander, les précautions d'emploi à observer pour réduire les effets secondaires des principaux médicaments pourvoyeurs d'effets indésirables et les médicaments dont le rapport bénéfice/risque est défavorable chez les sujets âgés. Ces recommandations sont synthétisées dans des tableaux didactiques conç us pour être imprimés dans un format de poche et être utilisés au quotidien par les prescripteurs quel que soit leur domaine d'activité, médicale, chirurgicale, ou pharmaceutique.
- Published
- 2015
- Full Text
- View/download PDF
36. Intérêt de l'ostéodensitométrie chez les sujets chuteurs
- Author
-
Patrick Seret, Olivier Beauchet, Véronique Breuil, Laure Chapuis, Pascal Guggenbuhl, Michel Brazier, Yves Rolland, Christian Marcelli, Maurice Audran, Michel Laroche, Patrice Fardellone, Karine Briot, Florence Trémollières, Georges Weryha, Cédric Annweiler, Jean-Bernard Gauvain, Thierry Thomas, Sauveur Bendavid, Philippe Orcel, Athanase Benetos, Olivier Hanon, Claude-Laurent Benhamou, Eric Lespessailles, Jean-Marc Feron, Valérie Bousson, François Puisieux, Brigitte Letombe, Gilles Berrut, Christian Roux, Martine Cohen-Solal, Eric Mallet, Jean-Claude Souberbielle, Hubert Blain, Bruno Sutter, Bernard Cortet, Roland Chapurlat, Patricia Dargent, Sami Kolta, Department of Geriatrics - Efficiency and Deficiency Laboratory, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Gérontopôle, Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Toulouse [Toulouse], Département de Médecine Interne et Gérontologie clinique, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Service de médecine interne et gérontologie clinique [Angers], Université d'Angers (UA)-Centre Hospitalier Universitaire d'Angers (CHU Angers), Imagerie Multimodale Multiéchelle et Modélisation du Tissu Osseux et articulaire (I3MTO), Université d'Orléans (UO), Service de médecine gériatrique, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service de médecine aïgue gériatrique [Nantes], PRES Université Nantes Angers Le Mans (UNAM)-Centre hospitalier universitaire de Nantes (CHU Nantes), Groupe d'Études Remodelage Osseux et bioMatériaux (GEROM), Université d'Angers (UA), Médecine générale, Inconnu, Service de radiologie Ostéo-Articulaire, Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Caractérisation du Tissu Osseux par Imagerie : techniques et applications, Service de rhumatologie [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de rhumatologie, CHU Amiens-Picardie, Centre Hospitalier Universitaire de Nice (CHU Nice)-Hôpital l'Archet, Centre hospitalier de Vitré, Physiopathologie, diagnostic et traitements des maladies osseuses / Pathophysiology, Diagnosis & Treatments of Bone Diseases (LYOS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Os et articulations, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de rhumatologie[Lille], Hôpital Roger Salengro [Lille]-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Mécanismes physiologiques et conséquences des calcifications cardiovasculaires: rôle des remodelages cardiovasculaires et osseux, Université de Picardie Jules Verne (UPJV)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Antoine [AP-HP], Centre de médecine gériatrique, Centre Hospitalier Régional d'Orléans (CHRO), Foie, métabolismes et cancer, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Centre de rhumatologie, CHU Purpan, Hôpital Jeanne de Flandres, Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre de référence des maladies rares du calcium et du phosphore, CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Service de Rhumatologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Service de gériatrie, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre de recherche Croissance et signalisation (UMR_S 845), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Calot, Institut Calot [Fondation Hopale], Centre de ménopause, Service d'Endocrinologie [CHRU Nancy], Biologie intégrative du tissu osseux, Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Centre de Rhumatologie [CHU Toulouse], Pôle Inflammation, infection, immunologie et loco-moteur [CHU Toulouse] (Pôle I3LM Toulouse), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Biologie Intégrative du Tissu Osseux (LBTO), Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5), Hôpital Paule de Viguier, CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ), Gérontopôle de Toulouse, CHU Toulouse [Toulouse], CHU Angers, Université d'Angers ( UA ) -CHU Angers, Imagerie Multimodale Multiéchelle et Modélisation du Tissu Osseux et articulaire ( I3MTO ), Université d'Orléans ( UO ), Centre Hospitalier Régional Universitaire de Nancy ( CHRU Nancy ), PRES Université Nantes Angers Le Mans ( UNAM ) -Centre hospitalier universitaire de Nantes ( CHU Nantes ), Remodelage osseux et biomatériaux, Université d'Angers ( UA ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP]-Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], CHU Nice-Hôpital l'Archet, Physiopathologie, diagnostic et traitements des maladies osseuses / Pathophysiology, Diagnosis & Treatments of Bone Diseases ( LYOS ), Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Paris Diderot - Paris 7 ( UPD7 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Hôpital Roger Salengro-Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), Centre de recherche en épidémiologie et santé des populations ( CESP ), Université de Versailles Saint-Quentin-en-Yvelines ( UVSQ ) -Université Paris-Sud - Paris 11 ( UP11 ) -Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université de Picardie Jules Verne ( UPJV ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Service de chirurgie orthopédique, CHU Saint-Antoine [APHP], Centre Hospitalier Régional d'Orléans ( CHR ), Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], Université de Lille, Droit et Santé-Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), CHU Caen, Assistance publique - Hôpitaux de Paris (AP-HP)-Hôpital Lariboisière, Centre Hospitalier Régional Universitaire [Lille] ( CHRU Lille ), Centre de recherche Croissance et signalisation ( UMR_S 845 ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), and Université Jean Monnet [Saint-Étienne] ( UJM ) -Institut National de la Santé et de la Recherche Médicale ( INSERM )
- Subjects
[ SDV.MHEP.RSOA ] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system ,Rheumatology ,Ostéodensitométrie ,Prise en charge ,[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system ,Ostéoporose ,Recommandations ,Chute ,Fragilité - Abstract
National audience; La présente revue de la littérature a pour objectif d'argumenter les nouvelles recommandations françaises publiées en 2012 retenant le risque de chute, évalué par l'antécédent de chute dans la dernière année, comme indication de la mesure de la densité minérale osseuse (DMO) par l'absorptiométrie biphotonique par rayons X (DXA). Cette recommandation repose sur le fait que premièrement, l'ostéoporose et le risque de chute représentent les deux premiers facteurs de risque de fracture non vertébrale après la ménopause. Deuxièmement, la mesure de la DMO par DXA apporte une information significative sur le risque de fracture, indépendamment du risque de chute. Ainsi, un sujet chuteur aura d'autant plus de risque de se fracturer qu'il aura une DMO basse. Troisièmement, les traitements anti-ostéoporotiques n'ont montré une efficacité anti-fracturaire qu'en cas d'ostéoporose ostéodensitométrique. Quatrièmement, la prévalence de l'ostéoporose est élevée chez les sujets chuteurs d'autant que ceux-ci sont fragiles [chutes répétées, sarcopénie (faible masse et force musculaire), réduction de mobilité, perte de poids, en particulier], ces facteurs étant des facteurs de risque communs d'ostéoporose et de chute. Cependant, l'indication de la DXA doit être nuancée chez les sujets chuteurs dont l'espérance de vie est limitée, les traitements n'ayant montré une efficacité anti-fracturaire qu'après 12 mois d'administration et en cas de faible accessibilité à la DXA (éloignement, patients dépendants, ayant une altération cognitive sévère par exemple). Des travaux sont souhaitables pour mieux définir comment intégrer le risque de chute et la fragilité dans l'évaluation du risque de fracture par la DMO et le score FRAX®
- Published
- 2014
- Full Text
- View/download PDF
37. Relationship between Inward Rectifier Potassium Current Impairment and Brain Injury after Cerebral Ischemia/Reperfusion
- Author
-
Régis Bordet, Qian Pu, Bernard Dupuis, Emmanuel Robin, Michèle Bastide, and François Puisieux
- Subjects
Male ,Middle Cerebral Artery ,medicine.medical_specialty ,Patch-Clamp Techniques ,Potassium Channels ,Vascular smooth muscle ,Cerebral arteries ,Ischemia ,Brain Edema ,Vasodilation ,Functional Laterality ,Muscle, Smooth, Vascular ,Membrane Potentials ,Potassium Chloride ,030218 nuclear medicine & medical imaging ,Brain ischemia ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,otorhinolaryngologic diseases ,medicine ,Animals ,Myocyte ,Potassium Channels, Inwardly Rectifying ,Rats, Wistar ,Cells, Cultured ,Inward-rectifier potassium ion channel ,business.industry ,Cerebral Infarction ,medicine.disease ,Potassium channel ,Rats ,Endocrinology ,Neurology ,Ischemic Attack, Transient ,Reperfusion ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,business ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Functional alterations of barium-sensitive potassium inward rectifier (Kir) current, which is involved in the vasodilation of middle cerebral arteries (MCA) in rat brain, have been described during brain ischemiaireperfusion (I/R). The authors investigate the effects of I/R on Kir current recorded in isolated myocytes from MCA of control rats and from contralateral and ipsilateral MCA of ischemic rats by the whole-cell patch-clamp technique, and the relationship between its alteration and The severity of brain injury. The vascular smooth muscle cells exhibited similar morphologic features in all conditions, and the Kir was present in the three groups of myocytes, exhibiting a characteristic inward rectification and a normal external potassium dependence. The Kir density was significantly reduced in cell of MCA ipsilateral to occlusion with a maximum at −135 mV, whereas there was no difference between control and contralateral cells. This alteration in Kir density in occluded MCA was significantly correlated with severity of brain injury and brain edema. These results suggest that the alteration of Kir density in MCA myocytes after I/R and the consecutive impaired dilation of MCA may contribute to aggravation of the brain injury.
- Published
- 1999
- Full Text
- View/download PDF
38. Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years
- Author
-
Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, Julien Labreuche, Anne Goffard, Jacques Trauet, Daniela Lupau, Sophie Miczek, Fanny Vuotto, Arnaud Dendooven, Dominique Huvent-Grelle, Juliette Podvin, Daniel Dreuil, Karine Faure, Dominique Deplanque, Laurence Bocket, Alain Duhamel, Annie Sobaszek, Didier Hober, Michael Hisbergues, Francois Puisieux, Brigitte Autran, Yazdan Yazdanpanah, Myriam Labalette, and Guillaume Lefèvre
- Subjects
BNT162b2 vaccine ,Boost ,SARS-CoV-2 ,Delta ,Omicron ,Older people ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: The present study aimed to evaluate the persistent immunogenicity offered by a third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) residents. Methods: In this monocenter prospective observational study, anti-spike IgG levels, S1 domain reactive T cell counts, serum neutralizing antibody titers against Delta and Omicron variants were compared before and up to three months after the BNT162b2 booster dose, in NH residents without COVID-19 (COVID-19 naive) or with COVID-19 prior to initial vaccination (COVID-19 recovered). Findings: 106 NH residents (median [interquartile range] age: 86·5 [81;91] years) were included. The booster dose induced a high increase of anti-spike antibody levels in all subjects (p
- Published
- 2022
- Full Text
- View/download PDF
39. Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres
- Author
-
Berengere Dumotier, François Puisieux, M. M. Adamantidis, and Bernard Dupuis
- Subjects
Purkinje fibers ,medicine.medical_treatment ,Prokinetic agent ,Action Potentials ,Torsades de pointes ,Pharmacology ,Afterdepolarization ,Purkinje Fibers ,Piperidines ,Torsades de Pointes ,medicine ,Animals ,Cisapride ,business.industry ,Arrhythmias, Cardiac ,Heart ,Cardiac action potential ,medicine.disease ,Electrophysiology ,medicine.anatomical_structure ,Potassium ,Rabbits ,business ,Anti-Arrhythmia Agents ,Research Article ,medicine.drug - Abstract
Cisapride, a gastrointestinal prokinetic agent, has been associated with cases of Torsades de Pointes but its effects on the cardiac action potential have not been described. We investigated its electrophysiological effects on rabbit isolated Purkinje fibres. The results demonstrated that cisapride (0.01-10 microM) lengthened concentration-dependently the action potential duration without modifying other parameters and induced early after depolarizations and subsequent triggered activity. This typical class III antiarrhythmic effect, that showed "reverse" rate-dependence and was reduced by increasing external K concentration, can account for clinical arrhythmogenesis.
- Published
- 1996
- Full Text
- View/download PDF
40. Ambulatory blood pressure monitoring and postprandial hypotension in elderly persons with falls or syncopes
- Author
-
Françoise Salomez-Granier, Anne Laure Fauchais, Hélène Bulckaen, François Puisieux, P. Dewailly, and Sylvie Drumez
- Subjects
Male ,Aging ,medicine.medical_specialty ,Ambulatory blood pressure ,Time Factors ,Systole ,Monitoring, Ambulatory ,Blood Pressure ,Syncope ,Diabetes Complications ,Eating ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,Aged ,Aged, 80 and over ,Meal ,Chi-Square Distribution ,business.industry ,digestive, oral, and skin physiology ,Middle Aged ,medicine.disease ,Circadian Rhythm ,Endocrinology ,Postprandial ,Blood pressure ,Ambulatory ,Cardiology ,Polypharmacy ,Accidental Falls ,Female ,Geriatrics and Gerontology ,Hypotension ,business ,Chi-squared distribution - Abstract
BACKGROUND Postprandial hypotension (PPH) is increasingly recognized as a common cause of falls and syncope in elderly persons. Noninvasive ambulatory blood pressure monitoring (ABPM) has been recommended for detecting PPH. This study investigates postprandial blood pressure (BP) changes by means of ABPM in elderly patients experiencing falls or syncopes. METHODS Twenty-four-hour ABPM was performed in 156 inpatients (111 women, mean age 80.4 +/- 8.1 years). Among them, 45 had been admitted for falls and 75 for syncope; 36 with no history of falls or syncope served as controls. Postprandial change in systolic blood pressure (deltaSBP) was calculated by subtracting the mean SBP within the 2 hours following the meal from the mean SBP within the 2 hours preceding the meal. PPH was defined by a deltaSBP > or = 20 mm Hg. RESULTS For the entire group, mean SBP decreased after the three meals. On average, the decline in SBP was greater after breakfast than after lunch or dinner, and the number of patients experiencing PPH was greater after breakfast. Average maximal deltaSBP was significantly larger in the syncope group than in the other groups ( p < .05). Moreover, the number of patients experiencing PPH was significantly higher in the syncope/fall group than in the control group (23% vs 9%; p = .03). Compared with patients without PPH, patients with PPH were more likely to have a history of diabetes mellitus (p < .01) or to use more than three different drugs daily ( p = .04), and they showed greater daytime SBP variability (p < .0001). Furthermore, there was a strong positive correlation between preprandial SBP and deltaSBP after breakfast. CONCLUSIONS About one out of four elderly patients with falls or syncope experiences PPH, usually after breakfast. Postprandial decline in BP contributes to BP variability. deltaSBP and preprandial SBP are positively correlated.
- Published
- 2000
41. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People
- Author
-
Julie Demaret, Bénédicte Corroyer-Simovic, Enagnon Kazali Alidjinou, Anne Goffard, Jacques Trauet, Sophie Miczek, Fanny Vuotto, Arnaud Dendooven, Dominique Huvent-Grelle, Juliette Podvin, Daniel Dreuil, Karine Faure, Dominique Deplanque, Laurence Bocket, Alain Duhamel, Julien Labreuche, Annie Sobaszek, Michael Hisbergues, Francois Puisieux, Myriam Labalette, and Guillaume Lefèvre
- Subjects
SARS – CoV – 2 ,vaccine ,older people and ageing ,T cells response ,mRNA vaccination ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Long-term care facility (LTCF) older residents display physiological alterations of cellular and humoral immunity that affect vaccine responses. Preliminary reports suggested a low early postvaccination antibody response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to focus on the specific T-cell response. We quantified S1-specific IgG, neutralizing antibody titers, total specific IFNγ-secreting T cells by ELISpot, and functionality of CD4+- and CD8+-specific T cells by flow cytometry, after two doses of the BNT162b2 vaccine in younger and older people, with and without previous COVID-19 infection (hereafter referred to as COVID-19-recovered and COVID-19-naive subjects, respectively). Frailty, nutritional, and immunosenescence parameters were collected at baseline in COVID-19-naive older people. We analyzed the immune response in 129 young adults (median age 44.0 years) and 105 older residents living in a LCTF (median age 86.5 years), 3 months after the first injection. Humoral and cellular memory responses were dramatically impaired in the COVID-19-naive older (n = 54) compared with the COVID-19-naive younger adults (n = 121). Notably, older participants’ neutralizing antibodies were 10 times lower than the younger’s antibody titers (p
- Published
- 2021
- Full Text
- View/download PDF
42. Parcours de soins du sujet âgé à partir du service de gériatrie aiguë : facteurs de risque issus d'analyses de la cohorte DAMAGE
- Author
-
Deschasse, Guillaume, Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université de Lille, François Puisieux, Frédéric Bloch, and STAR, ABES
- Subjects
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,Care pathway ,Acute geriatric unit ,Rehabilitation ,Rééducation ,Mortalité ,Older ,Palliative care ,Parcours de soins ,Soins palliatifs ,Unité de gériatrie aigue ,Mortality ,Patient âgé ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
Context: optimising care pathways for the elderly is a major challenge in view of the ageing population. The acute geriatric unit (AGU) is a "pivotal" hospital care unit in the care pathway of the elderly.Objectives: to identify the risk factors for transfer to follow-up care and rehabilitation upon admission to the AGU, to describe the association between end-of-life trajectories and transition to exclusive comfort care for patients who die in the AGU, to develop and validate a prognostic score for individual and collective risk of mortality in the medium and long term (3 and 12 months respectively) after discharge from the AGU.Method: we conducted a series of analyses on data from the DAMAGE cohort. The DAMAGE cohort is a prospective multicentre study that consecutively included 3509 subjects aged 75 years or more hospitalised in the AGU. These patients underwent a broad comprehensive geriatric assessment during their stay and a description of their care pathway was collected.Results: 1928 patients were included for the search of risk factors for transfer to post-acute hospital care facility. Significant loss of functional independence, high ADL score at home, low ADL score at admission, living alone, social isolation and delirium were risk factors for transfer to post-acute hospital care facility. Obesity, high serum albumin and community infection were associated with return home.123 (69.5%) decedents received comfort care only. The frailty-related end-of-life trajectory (with or without dementia) accounted for almost 70% of deaths. Frailty in the absence of established dementia was not associated with a more frequent transition to comfort care only (odds ratio [95% CI]: 1.44 [0.44- 4.76]).3112 frail or dependent elderly patients with a high proportion of deaths at 3 months (n=455, 14.8%) and 12 months (n=1014, 33%) were included for the mortality score. The score predicted an individual risk of mortality of between 1% and 80% at 3 months and between 5% and 93% at 12 months, with a C-statistic in the validation cohort of 0.728 at 3 months and 0.733 at 12 months.Conclusion: This series of analyses allows us to better describe and identify certain risk factors useful for optimising and planning the care pathway of elderly patients in the UGA and beyond their stay in the UGA., Contexte : l'optimisation des parcours de soins des personnes âgées est un défi majeur au vu du vieillissement de la population. L'unité de gériatrie aiguë (UGA) est une unité de soins hospitaliers « pivot » dans le parcours de soins des personnes âgées.Objectifs : identifier les facteurs de risque (FDR) de transfert en soins de suite et réadaptation (SSR) dès l'admission en UGA, décrire l'association entre trajectoires de fin de vie et transition en soins de confort exclusifs pour les patients décédés en UGA, développer et valider un score pronostique du risque individuel et du risque collectif de mortalité à moyen et long terme (respectivement 3 et 12 mois) après la sortie de l'UGA.Méthode: nous avons conduit une série d'analyses sur les données de la cohorte DAMAGE. La cohorte DAMAGE est une étude prospective multicentrique qui a inclus consécutivement 3509 sujets âgés de 75 ans ou plus hospitalisés en UGA. Ces patients ont bénéficié d'une large évaluation gériatrique standardisée au cours de leur séjour et la description de leur parcours de soins a été recueillie.Résultats : 1928 patients ont été inclus pour la recherche de FDR de transfert en SSR. Une perte d'indépendance fonctionnelle importante, un score ADL élevée à domicile, un score ADL bas à l'admission, vivre seul, d'être isolé socialement et le syndrome confusionnel étaient des FDR de transfert vers le SSR. L'obésité, un taux sérique d'albumine élevé et une infection communautaire étaient associés au retour au domicile. 123 (69,5%) décédés ont bénéficié de soins de confort exclusifs. La trajectoire de fin de vie liée à la fragilité (avec ou sans troubles neurocognitifs majeurs (TNCM)) représentait près de 70% des décès. La fragilité en l'absence de TNCM établis n'était pas associée à une transition plus fréquente vers les soins de confort exclusifs (odds ratio [IC 95%] : 1,44 [0,44- 4,76]). 3112 patients âgés et fragiles ou dépendants, avec une forte proportion de décès à 3 mois (n=455, 14,8%) et à 12 mois (n=1014, 33%) ont été inclus pour la réalisation du score de mortalité. Le score prédit un risque individuel de mortalité compris entre 1% et 80% à 3 mois et entre 5% et 93% à 12 mois, avec une statistique C dans la cohorte de validation de 0,728 à 3 mois et 0,733 à 12 mois.Conclusion : cette série d'analyses permet de mieux décrire et identifier certains FDR utiles pour l'optimisation et la planification du parcours de soins des patients âgés en UGA et au-delà de leur séjour en UGA.
- Published
- 2022
43. Le vieillissement artériel dans un modèle de vieillissement physiologique et un modèle de vieillissement accéléré, le diabète: aspect fonctionnel et morphologique. Intérêt respectif de l'aspirine et de l'aminoguanidine
- Author
-
Bulckaen, Helene, Pharmacologie de la mort neuronale et de la plasticité cérébrale, IFR114-Université de Lille, Droit et Santé, Université du Droit et de la Santé - Lille II, François Puisieux(f-puisieux@chru-lille.fr), Faculté de médecine de Lille, Laboratoire d'anatomo-pathologie, Université du Littoral, Laboratoire de toxicologie, de l'industrie et de l'environnement, Dunkerque, Laboratoire de biologie vasculaire et cellulaire, Hôpital Lariboisière, Paris, and Bulckaen, Helene
- Subjects
[SDV] Life Sciences [q-bio] ,endothélium ,[SDV]Life Sciences [q-bio] ,aging ,artères ,artery ,vieillissement - Abstract
Age-associated or diabetes arterial changes such as endothelial dysfunction are involved in the significantly increased risk of cardiovascular complications. The presence of endothelial dysfunction in the coronary or peripheral circulation has been shown to constitute a risk factor for cardiovascular events independent of the development of atherosclerosis or other vascular risk factors. Therapeutic approaches capable of preventing or reversing age-related endothelial dysfunction may thus help to reduce cardiovascular risk. The aim of the study was to determine the effects of two treatments, one on age-related endothelial dysfunction, the other on diabetes endothelial dysfunction. For primary and secondary prevention, aspirin can reduce the incidence of cardiovascular events. The first part of the present work evaluated the effect of low-dose aspirin on age-related endothelial dysfunction in C57B/J6 aging mice. Age-related endothelial dysfunction was assessed by the response to acetylcholine (ACh) of phenylephrine (Phe)-induced precontracted aortic segments isolated from 12-, 36-, 60- and 84-week-old mice. The effect of low-dose aspirin was examined in mice presenting a decrease in endothelial-dependent relaxation. The effects of age and aspirin treatment on structural changes were determined in mouse aortic sections. The effect of aspirin on the oxidative stress markers malondialdehyde (MDA) and 8-hydroxy-2'-deoxyguanosine (8-OhdG) was in addition quantified. Compared to that of 12-week-old mice, the EDR was significantly reduced in 60- and 84-week-old mice (p, Les modifications artérielles liés au vieillissement ou au diabète telles que la dysfonction endothéliale contribuent à augmenter le risque de survenue d'événements cardiovasculaires. La dysfonction endothéliale, coronaire ou périphérique, est reconnue comme un facteur indépendant de survenue d'évènements cardiovasculaires indépendamment de la présence d'athérosclérose ou de facteur de risque d'athérosclérose. Des approches thérapeutiques capables de prévenir ou de restaurer la dysfonction endothéliale pourrait aider à réduire le risque de survenue d'accidents cardiovasculaires. Ce travail a pour but d'évaluer les effets de deux molécules, l'une sur la dysfonction endothéliale liée à l'âge, l'autre sur la dysfonction liée au diabète. En prévention primaire et secondaire, l'aspirine à faible dose réduit l'incidence des évènements cardiovasculaires. La première partie de ce travail étudie les effets de l'aspirine à faible dose sur la dysfonction endothéliale chez des souris C57B/J6. La dysfonction endothéliale liée à l'âge est établie par la réponse à l'acétylcholine (ACh) de segments aortiques précontractés par phenylephrine (Phe) et isolés de souris âgées de 12-, 36-, 60- et 84 semaines. Les effets de l'aspirine à faible dose sont étudiés chez des souris présentant une altération de la relaxation endothélium-dépendante. Les effets de l'âge et du traitement par aspirine sur la structure de la paroi ont été déterminés sur des coupes aortiques de souris. Les effets de l'aspirine sur des marqueurs du stress oxydants, le malondialdehyde (MDA) et l'8-hydroxy-2'-deoxyguanosine (8-OhdG) ont été étudiés. Comparée à celle des souris âgées de 12 semaines, la relaxation endothelium-dépendante était significativement réduite chez les souris âgées de 60- et 84-semaines (p
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.